var title_f21_3_21552="Septic emboli MRSA osteo";
var content_f21_3_21552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary septic emboli in community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) osteomyelitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography of the chest in a 9-year-old with CA-MRSA osteomyelitis of the tibia demonstrating multiple nodules consistent with pulmonary emboli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sheldon L Kaplan, MD. Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21552=[""].join("\n");
var outline_f21_3_21552=null;
var title_f21_3_21553="Patient information: Erythema multiforme (The Basics)";
var content_f21_3_21553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16987\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/62/15329\">",
"         Erythema multiforme",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Erythema multiforme (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/erythema-multiforme-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H6064945\">",
"      <span class=\"h1\">",
"       What is erythema multiforme?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Erythema multiforme is a condition that causes red spots on the skin. The spots often have a dark center surrounded by pale red rings, like a target or bull&rsquo;s-eye (",
"      <a class=\"graphic graphic_picture graphicRef66481 \" href=\"UTD.htm?14/62/15329\">",
"       picture 1",
"      </a>",
"      ). Sometimes, the spots have blisters.",
"     </p>",
"     <p>",
"      The spots can appear in different places on the body, including the:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Arms and legs",
"       </li>",
"       <li>",
"        Chest and back",
"       </li>",
"       <li>",
"        Face and neck",
"       </li>",
"       <li>",
"        Palms of the hands",
"       </li>",
"       <li>",
"        Soles of the feet",
"       </li>",
"       <li>",
"        Lips, tongue, and gums",
"       </li>",
"       <li>",
"        Near the eyes",
"       </li>",
"       <li>",
"        Genital area",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The spots might itch or burn. Some people have a fever and feel tired and achy before the spots appear. The spots usually show up over 3 to 5 days. They disappear in about 2 weeks.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6064960\">",
"      <span class=\"h1\">",
"       What causes erythema multiforme?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most of the time, erythema multiforme is caused by an infection. But medicines can cause erythema multiforme, too.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6064975\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your nurse or doctor should be able to tell if you have erythema multiforme by looking at your skin and doing an exam. He or she might also take a small skin sample and a blood sample. These samples will help your doctor make sure your symptoms aren&rsquo;t being caused by another medical condition.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6064992\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can try putting a cool, damp cloth on the area with the spots. You can also take over-the-counter medicines such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?24/60/25537?source=see_link\">",
"         Diphenhydramine",
"        </a>",
"        (sample brand name: Benadryl&reg;) for itching and swelling",
"       </li>",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"         Acetaminophen",
"        </a>",
"        (sample brand name: Tylenol&reg;) for fever and discomfort",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6065007\">",
"      <span class=\"h1\">",
"       How is erythema multiforme treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include medicines to ease itching and pain. Some medicines are creams that you rub on your skin. Others are pills.",
"     </p>",
"     <p>",
"      If you have spots in your mouth, your doctor might give you a special mouthwash to help relieve the pain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6065022\">",
"      <span class=\"h1\">",
"       Can erythema multiforme be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your condition was caused by a medicine, do not take that medicine again. Talk to your doctor or nurse about switching to a different medicine.",
"     </p>",
"     <p>",
"      Some people who are infected with a certain virus keep getting erythema multiforme over and over again. If you get erythema multiforme more than several times a year, talk with your doctor or nurse. He or she might give you a medicine to take every day that will help keep you from getting it so often.",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/3/21553?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16987 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-57BF54AE18-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21553=[""].join("\n");
var outline_f21_3_21553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6064945\">",
"      What is erythema multiforme?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6064960\">",
"      What causes erythema multiforme?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6064975\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6064992\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6065007\">",
"      How is erythema multiforme treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6065022\">",
"      Can erythema multiforme be prevented?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16987\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/62/15329\">",
"      Erythema multiforme",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21554="Castor oil: Drug information";
var content_f21_3_21554=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Castor oil: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/3/19506?source=see_link\">",
"    see \"Castor oil: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F146853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Laxative, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F146846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Bowel evacuation, constipation:",
"     </b>",
"     Oil: Oral: 15-60 mL as a single dose",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F146850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/3/19506?source=see_link\">",
"      see \"Castor oil: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Bowel evacuation, constipation:",
"     </b>",
"     Oil: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children 2-11 years: 5-15 mL as a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F146847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F146837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oil, oral: 100% (60 mL, 120 mL, 180 mL, 480 mL, 3840 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F146824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Oil",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F146839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not administer at bedtime because of rapid onset of action. Should be administered on an empty stomach with juice or carbonated beverages.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F146838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Preparation for rectal or bowel examination or surgery; rarely used to relieve constipation; also applied to skin as emollient and protectant",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F146851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Electrolyte disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, diarrhea, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Pelvic congestion",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F146831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14206268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ingestion of castor oil may be associated with induction of labor. Use of castor oil as a laxative during pregnancy should be avoided (Cullen, 2007; Hall, 2011; Wald, 2003).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F146842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken on an empty stomach with juice or carbonated beverages.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Oleum Ricini (BG, EE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F146827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts primarily in the small intestine; hydrolyzed to ricinoleic acid which reduces net absorption of fluid and electrolytes and stimulates peristalsis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F146841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action: 2-6 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cullen G and O'Donoghue D, \"Constipation and Pregnancy,\"",
"      <i>",
"       Best Pract Res Clin Gastroenterol",
"      </i>",
"      , 2007, 21(5):807-18.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/3/21554/abstract-text/17889809/pubmed\" id=\"17889809\" target=\"_blank\">",
"        17889809",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hall HG, McKenna LG, and Griffiths DL, \"Complementary and Alternative Medicine for Induction of Labour,\"",
"      <i>",
"       Women Birth",
"      </i>",
"      , 2011.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/3/21554/abstract-text/21524953/pubmed\" id=\"21524953\" target=\"_blank\">",
"        21524953",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wald A, \"Constipation, Diarrhea, and Symptomatic Hemorrhoids During Pregnancy,\"",
"      <i>",
"       Gastroenterol Clin North Am",
"      </i>",
"      , 2003, 32(1):309-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/3/21554/abstract-text/12635420/pubmed\" id=\"12635420\" target=\"_blank\">",
"        12635420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8846 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-FC54B750F8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21554=[""].join("\n");
var outline_f21_3_21554=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146853\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146846\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146850\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146847\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146837\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146824\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146839\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146838\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146851\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298980\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146831\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14206268\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146842\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038552\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146827\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146841\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8846\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8846|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/3/19506?source=related_link\">",
"      Castor oil: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21555="Mouth cancer PI";
var content_f21_3_21555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F50104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F50104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Mouth cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 224px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These are 2 examples of mouth cancer. Photo A shows a white growth on the tongue, and photo B shows a red growth on the lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21555=[""].join("\n");
var outline_f21_3_21555=null;
var title_f21_3_21556="Excision duplication cyst";
var content_f21_3_21556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transcervical excision of enteric duplication cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21556=[""].join("\n");
var outline_f21_3_21556=null;
var title_f21_3_21557="Bianchi procedure";
var content_f21_3_21557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Longitudinal intestinal lengthening and tailoring (Bianchi procedure) for short bowel syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 497px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bianchi, A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction. Gastroenterology 2006; 130:S138. Copyright &copy;2006 The American Gastroenterological Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21557=[""].join("\n");
var outline_f21_3_21557=null;
var title_f21_3_21558="Pegylated interferon (peginterferon) alfa-2a: Patient drug information";
var content_f21_3_21558=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pegylated interferon (peginterferon) alfa-2a: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/27/27064?source=see_link\">",
"     see \"Pegylated interferon (peginterferon) alfa-2a: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/61/8152?source=see_link\">",
"     see \"Pegylated interferon (peginterferon) alfa-2a: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pegasys&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F206900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pegasys&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Alpha interferons may cause or make diseases of the mind worse. Taking one's own life, ideas of killing yourself or murder, low mood (depression), forceful actions, hallucinations, psychoses, and relapse of drug addiction have happened with use. Alpha interferons may make infections worse, cause blood flow problems or some autoimmune diseases. If you think you have any of these health problems, call your doctor right away. Side effects such as low blood pressure, a fast heartbeat, and heart attacks have happened while taking alpha interferons. If you have very bad signs or if signs of these health problems get worse, talk with your doctor about stopping this drug. Problems are most often fixed after you stop the drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700890",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take with ribavirin if you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691880",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hepatitis B and C infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to peginterferon alfa-2a or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Autoimmune hepatitis, confusion caused by liver disease, or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been treated with interferon.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain or bloody loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More trips to the bathroom, more thirst, or weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695948",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot is most often given once a week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not getting better after 3 months of therapy, the drug is most often stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to give closely if you or a family member is giving the shot at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw syringe away after use. Do not use more than one time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696493",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to time for your next dose, skip the missed dose and call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not shake.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part of opened vial not used after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10951 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-043A92644E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21558=[""].join("\n");
var outline_f21_3_21558=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206899\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206900\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030640\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030642\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030641\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030646\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030647\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030649\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030644\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030645\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030650\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030651\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/27/27064?source=related_link\">",
"      Pegylated interferon (peginterferon) alfa-2a: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/61/8152?source=related_link\">",
"      Pegylated interferon (peginterferon) alfa-2a: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21559="Cervicofacial actinomycosis";
var content_f21_3_21559=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cervicofacial actinomycosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Abdu A Sharkawy, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Anthony W Chow, MD, FRCPC, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21559/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/3/21559/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervicofacial actinomycosis is a chronic disease characterized by abscess formation, draining sinus tracts, fistulae, and tissue fibrosis. It can mimic a number of other conditions, particularly malignancy and granulomatous disease, and should be included in the differential diagnosis of any soft tissue swelling in the head and neck. Cervicofacial involvement is the most common manifestation of actinomycosis, accounting for 50 percent of all cases, while central nervous system (CNS), thoracic, abdominal, and pelvic actinomycosis occur less frequently [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cervicofacial actinomycosis will be reviewed here. Ileocecal actinomycosis and actinomycosis related to intrauterine devices (IUDs) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38452?source=see_link\">",
"     \"Abdominal actinomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link\">",
"     \"Overview of intrauterine contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervicofacial actinomycosis is caused by branching gram-positive bacteria belonging to the order Actinomycetales, family Actinomycetaceae, genus Actinomyces [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. Of note, both Mycobacteria and Nocardia species also belong to the same order, and infections caused by these microbes may at times be difficult to distinguish from Actinomyces [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. Actinomycosis was originally described in 1878 by Israel [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/4\">",
"     4",
"    </a>",
"    ], and later by Wolfe [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/5\">",
"     5",
"    </a>",
"    ] who isolated the causative organism and defined its anaerobic nature [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Actinomyces are non-spore-forming, strict or facultative anaerobes with a variable cellular morphology, ranging from diphtheroidal to coccoid filaments (",
"    <a class=\"graphic graphic_picture graphicRef68050 \" href=\"UTD.htm?39/40/40591\">",
"     picture 1",
"    </a>",
"    ). They are normal constituents of the oral flora within gingival crevices and tonsillar crypts and are particularly prevalent in periodontal pockets, dental plaques, and on carious teeth [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36569?source=see_link\">",
"     \"Deep neck space infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Distinguishing features from fungi",
"    </span>",
"    &nbsp;&mdash;&nbsp;The name actinomycosis literally translates as \"ray fungus\" and reflects its filamentous, fungal-like characteristic appearance in infected tissues. However, Actinomyces are true bacteria with filaments much narrower than fungal hyphae. While actinomycotic filaments readily fragment into bacillary forms, tubular hyphae of molds never fragment and exhibit distinct branching patterns. Another distinguishing feature between actinomyces and fungi is the method of reproduction, which occurs by binary fission in actinomyces and not by spore-formation or budding as in fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Growth characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinomyces are fastidious organisms that require an enriched medium (such as brain-heart infusion broth) for growth. Incubation at 37&ordm; C with 6 to 10 percent carbon dioxide provides for optimal growth conditions. Given their slow-growing nature, cultures should be observed for at least 14 to 21 days to allow adequate detection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ]; this should be specifically requested of the clinical microbiology laboratory if actinomyces are suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Infecting species",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human actinomycosis is primarily caused by A. israelii. At least 30 different Actinomyces species have been described. Many are known to cause disease in humans, including: A. odontolyticus, A. naeslundii, A. meyeri, A. viscosus, A. funkei, A. gerencseriae, A. pyogenes, A. urogenitalis, A. georgiae, and A. graevenitzii [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. Other implicated species include Propionibacterium propionicus (formerly Arachnia propionicus) as well as the coryneform bacteria, A. neuii, A. radingae, and A. turicensis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6,11\">",
"     6,11",
"    </a>",
"    ]. A. bovis causes the disease known as \"lumpy jaw\" in cattle but does not cause disease in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Coinfecting organisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinomyces are almost invariably isolated as part of a polymicrobial flora. In one study of more than 650 cases of actinomycosis, Actinomyces were not isolated in pure culture in a single case [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/13\">",
"     13",
"    </a>",
"    ]. Aggregatibacter (Actinobacillus) actinomycetemcomitans and Haemophilus aphrophilus were the most common coisolates in this study. Other bacteria frequently isolated along with Actinomyces include: Eikenella corrodens, Fusobacterium, Bacteroides, Capnocytophaga, Staphylococcus, Streptococcus, and Enterococcus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6,14\">",
"     6,14",
"    </a>",
"    ]. However, the significance of these coexisting bacteria in the pathogenesis of actinomycosis remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Sulfur granules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinomyces are noted for forming characteristic sulfur granules in infected tissue but not in vitro. The term \"sulfur granule\" is a misnomer, reflecting only the yellow color of the granule in pus, since they are not composed of any sulfur at all. The granules are actually discrete, macroscopic grains of hard consistency, 100 to 1000 &micro;m in diameter, often visible to the naked eye or by microscopy with low magnification (10x) (",
"    <a class=\"graphic graphic_figure graphicRef81782 \" href=\"UTD.htm?33/19/34096\">",
"     figure 1",
"    </a>",
"    ). They are composed of an internal tangle of mycelial fragments and a rosette of peripheral clubs.",
"   </p>",
"   <p>",
"    The granule is stabilized by a protein-polysaccharide complex and mineralized by host calcium phosphate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. Some authors suggest that the protein-polysaccharide complex provides a mechanism of resistance to host phagocytic activity. Filaments within a granule are often seen by Gram or silver",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/57/3989?source=see_link\">",
"     methenamine",
"    </a>",
"    stain, though more calcified granules may be difficult to identify [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar granules may be formed by other microorganisms, notably Nocardia brasiliensis and Streptomyces madurae (both can cause mycetoma), as well as Staphylococcus aureus (a cause of botryomycosis). These other granules are best distinguished by an absence of peripheral clubs, which appear to be specific to Actinomyces species. However, not all Actinomyces species form sulfur granules (eg, A. odontolyticus), and a peripheral fringe of clubs may be absent in certain instances, such as in a tonsillar crypt infection in which there is a minimal surrounding tissue reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While not typically considered as opportunistic pathogens, Actinomyces species capitalize on tissue injury or mucosal breach to invade adjacent structures in the head and neck regions. As a result, dental infections and oromaxillofacial trauma are common antecedent events [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/12\">",
"     12",
"    </a>",
"    ]. Disease occurs almost exclusively by direct invasion and rarely by hematogenous spread. A hallmark of cervicofacial actinomycosis is the tendency to spread without regard for anatomical barriers, including fascial planes or lymphatic drainage, and the development of multiple sinus tracts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinomyces are not found in the environment, and humans are the only natural reservoir for the species that cause cervicofacial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ]. Cervicofacial actinomycosis is a relatively rare condition but has a worldwide distribution with no predilection for age, race, season, or occupation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. However, there is a male to female predominance of 1.5 to 3:1 reported in many series [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Predisposing conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Predisposing factors include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dental caries and extractions",
"     </li>",
"     <li>",
"      Gingivitis and gingival trauma",
"     </li>",
"     <li>",
"      Infection in erupting secondary teeth",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adult males with poor oral hygiene appear to be at greatest risk. Other predisposing conditions include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Immunosuppression",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"     <li>",
"      Local tissue damage caused by neoplastic disease or irradiation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of actinomycosis in children should arouse suspicion of an underlying immunodeficiency state, particularly chronic granulomatous disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervicofacial actinomycosis can present with variable signs and symptoms, but it usually evolves in one of two distinct patterns. Typically, the infection presents as a chronic, slowly progressive, non-tender, indurated mass, which evolves into multiple abscesses, fistulae, and draining sinus tracts. Less commonly, it may present as an acute suppurative infection with rapid progression to abscess formation. At this stage, pain and trismus may arise which appear disproportionate to the local (visible) inflammation. With perimandibular space infections, inflammation of the muscles of mastication may also elicit significant pain and trismus. Fistulization from the perimandibular region is the most easily recognized manifestation of cervicofacial actinomycosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pain is generally an uncommon feature, particularly in chronic cases, although it may be prominent as a result of compression of adjacent structures in the ororespiratory tract such as the tongue [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/12,19\">",
"     12,19",
"    </a>",
"    ]. Dyspnea and dysphagia may occur but are distinctly uncommon. Fever and constitutional symptoms, including fatigue and malaise, are occasionally noted in the acute, pyogenic form of the disease. Because actinomycosis spreads by direct extension without regard for normal tissue planes, regional lymphadenopathy is rare until quite late in the disease course [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic lesions usually develop slowly, over weeks to months, with adherence to overlying skin giving it a bluish or reddish appearance. This is often mistaken for cellulitis but, in fact, more likely represents venous congestion. Over time, sinus tracts invariably form on the skin surface or oral mucosa, eventually erupting to express a thick yellow or serous exudate, which yields the characteristic sulfur granules [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. An inflammatory, cicatricial scarring is one of the more noticeable long-term sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cervicofacial actinomycosis may involve almost any tissue or structure surrounding the upper or lower mandible. However, the mandible itself is consistently the most commonly identified site of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. In one study of 317 patients reported from Cologne between 1952 and 1975, the presenting sites were identified as [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mandible &mdash; 53.6 percent",
"     </li>",
"     <li>",
"      Cheek &mdash; 16.4 percent",
"     </li>",
"     <li>",
"      Chin &mdash; 13.3 percent",
"     </li>",
"     <li>",
"      Submaxillary ramus and angle &mdash; 10.7 percent",
"     </li>",
"     <li>",
"      Upper jaw &mdash; 5.7 percent",
"     </li>",
"     <li>",
"      Mandibular joint &mdash; 0.3 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While direct bony invasion is decidedly uncommon, periostitis and post-traumatic osteomyelitis occurred in 11.7 percent of cases in this study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/21\">",
"     21",
"    </a>",
"    ]. Although most cases of cervicofacial actinomycosis are of odontogenic origin, primary infections have been reported in various other structures within the head and neck, often quite remote from any potential periodontal source. In particular, actinomycosis involving the scalp, tongue, maxillary sinus, ethmoid sinus, thyroid gland, thyroidectomy incision site, and lungs have all been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/19,22-24\">",
"     19,22-24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervicofacial actinomycosis has been dubbed \"the great masquerader of head and neck disease\" [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/25\">",
"     25",
"    </a>",
"    ]. This serves to highlight not only its elusive nature, but also the lack of familiarity to most clinicians. As a consequence, appropriate steps to obtain an adequate specimen for histopathologic examination and culture are often neglected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pitfalls in the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervicofacial actinomycosis often responds, at least temporarily, to short courses of broad-spectrum antibiotics given in the mistaken belief that the patient has a bacterial odontogenic infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/53/20313?source=see_link\">",
"     \"Complications, diagnosis, and treatment of odontogenic infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This approach leads to two key problems [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolation of the causative organisms from patients who have received antibiotics within 7 to 10 days is extremely rare.",
"     </li>",
"     <li>",
"      As the diagnosis is delayed, chronicity of the disease course and fibrosis is further encouraged. The enhanced fibrosis also hinders the identification of typical sulphur granules by histologic examination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As the disease progresses with repeated courses of antibiotic therapy, the fibrotic and \"woody\" induration often comes to resemble a malignant process. Occasionally, the granulomatous appearance of a biopsy specimen is mistaken for tuberculous disease. Perhaps even more commonly, granules are misidentified by staining or biopsy as an indication of nocardiosis. However, these pitfalls can be avoided by bearing in mind that malignant lesions should not respond at all to antimicrobial therapy, and that both Nocardia and mycobacterial species are typically acid fast, while Actinomyces are not. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29560?source=see_link\">",
"     \"Treatment of nocardiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Definitive diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinomycosis is usually diagnosed by culturing the organism, although the specimens must be handled properly and, as noted above, cultures held for at least 14 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confirmation of the diagnosis requires the recovery of Actinomyces species from an appropriately cultured specimen, typically by needle aspiration of an abscess, fistula or sinus tract or from a large biopsy specimen. Care needs to be taken to avoid contamination by other commensal flora from the oral cavity. Incubation of specimens under strict anaerobic or at least microaerophilic conditions for a minimum of 14 days is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sections of a biopsy specimen from different tissue levels are suggested to improve histologic diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3,27\">",
"     3,27",
"    </a>",
"    ]. Sections of biopsy material typically reveal acute or chronic inflammatory granulation tissue with infiltration by neutrophils, foamy macrophages, plasma cells and lymphocytes, and a surrounding dense fibrosis. Healing lesions tend to demonstrate profound fibrosis, even avascular in nature, often in proximity to areas of acute suppuration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"     3",
"    </a>",
"    ]. Sulfur granules may comprise no more than 1 percent of total tissue in a given lesion, and hence are easily missed by routine tissue staining. Often, a series of biopsies is required to confirm a pathologic diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/20\">",
"     20",
"    </a>",
"    ]. Furthermore, filaments of Nocardia and Actinomyces species are next to impossible to differentiate by conventional methods such as Grocott-Gomori-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/57/3989?source=see_link\">",
"     methenamine",
"    </a>",
"    stain and hematoxylin-eosin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. Other methods, including p-aminosalicylic acid, MacCallen-Goodpasture, and Brown-Brenn stains do not appear to offer additional sensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Monoclonal antibody staining",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast, specific staining using fluorescent-conjugated monoclonal antibody (FA) has been shown to improve the identification of various Actinomyces species, even in mixed infections and after fixation in formalin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ]. An additional advantage is the ability to define single filaments in granulation tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serology does not appear to be a practical or reliable diagnostic tool. While agglutinins and complement-fixing antibodies appear in the serum of some patients with cervicofacial actinomycosis, they may represent cross-reactive antibodies due to other disease processes, particularly tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/28\">",
"     28",
"    </a>",
"    ]. Rapid serodiagnosis by the detection of specific antibodies using immunoelectrophoresis or monospecific antigens is under development, but they are not widely available for clinical use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No randomized controlled studies have evaluated antibiotic regimens for cervicofacial actinomycosis. Treatment regimens are based on in vitro antibiotic susceptibility testing and small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Management of cervicofacial actinomycosis often requires prolonged courses of antibiotics. Surgical intervention may also be necessary in more complicated cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend high-dose penicillin as the treatment of choice for actinomycosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6,32\">",
"     6,32",
"    </a>",
"    ]. For mild infections, where significant suppuration or fistulous tracts are absent, oral antimicrobial therapy is appropriate. We recommend oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"     penicillin V",
"    </a>",
"    (2 to 4",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    in four divided daily doses) for an extended course of two to six months. Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    (500 mg three times daily) is probably equally efficacious [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/29\">",
"     29",
"    </a>",
"    ]. Acceptable alternatives to penicillin include the tetracyclines,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Various other agents are generally deemed to have poor activity against Actinomyces species and should probably be avoided. These include oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    , the fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    , aminoglycosides, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"     aztreonam",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/33,35\">",
"     33,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with penicillin allergy, the tetracyclines probably offer the best alternative, especially in milder disease presentations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/34,36\">",
"     34,36",
"    </a>",
"    ]. Therapy does not need to be directed against other commensal flora that are recovered along with Actinomyces species, since antibiotic regimens effective against Actinomyces alone are usually curative [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with more severe cervicofacial actinomycosis that require surgery (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Surgery'",
"    </a>",
"    below), intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    (10 to 20 million units daily in divided doses every four to six hours) for four to six weeks, followed by oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"     penicillin V",
"    </a>",
"    (2 to 4 g per day in divided doses every six hours) for 6 to 12 months is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/29,36\">",
"     29,36",
"    </a>",
"    ]. The duration of therapy should be guided by the severity of infection and an ongoing assessment for clinical or pathologic remission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;For more complicated cases, surgical excision of recalcitrant fibrotic lesions or drainage of extensive abscesses with marsupilation of persisting sinus tracts is often required for definitive cure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/37\">",
"     37",
"    </a>",
"    ]. Surgical intervention is also recommended for excision of necrotic tissue and curettage of affected bony tissue. However, surgical management alone is rarely successful as definitive treatment without concurrent antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combined medical-surgical approach usually results in a successful clinical response [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ]. However, prolonged observation of patients following treatment is recommended in order to promptly identify those with recurrences.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no defined measures for preventing cervicofacial actinomycosis. However, maintenance of good oral hygiene and appropriate dental plaque removal can limit the tendency of Actinomyces to establish dense colonization and subclinical periodontal infection, an important precipitating event for more extensive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cervicofacial actinomycosis is a chronic disease characterized by abscess formation, draining sinus tracts, fistulae, and tissue fibrosis. It can mimic a number of other conditions, particularly malignancy and granulomatous disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cervicofacial actinomycosis is caused by branching gram-positive bacteria with a variable cellular morphology, ranging from diphtheroidal to coccoid filaments (",
"      <a class=\"graphic graphic_picture graphicRef68050 \" href=\"UTD.htm?39/40/40591\">",
"       picture 1",
"      </a>",
"      ) belonging to the genus Actinomyces. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Actinomyces are noted for forming characteristic sulfur granules in infected tissue but not in vitro (",
"      <a class=\"graphic graphic_figure graphicRef81782 \" href=\"UTD.htm?33/19/34096\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Sulfur granules'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A hallmark of cervicofacial actinomycosis is the tendency to spread without regard for anatomical barriers, including fascial planes or lymphatic drainage, and the development of multiple sinus tracts. Actinomyces species capitalize on tissue injury or mucosal breach to invade adjacent structures; dental infections and oromaxillofacial trauma are common antecedent events. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Predisposing factors include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dental caries and extractions",
"     </li>",
"     <li>",
"      Gingivitis and gingival trauma",
"     </li>",
"     <li>",
"      Infection in erupting secondary teeth",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Immunosuppression",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"     <li>",
"      Local tissue damage caused by neoplastic disease or irradiation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Predisposing conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Actinomycosis typically presents as a chronic, slowly progressive, non-tender, indurated mass, which evolves into multiple abscesses, fistulae, and draining sinus tracts. Less commonly, it may present as an acute suppurative infection with a rapidly progressive, fluctuant, and pyogenic mass. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Confirmation of the diagnosis of actinomycosis requires the recovery of Actinomyces species from an appropriately cultured specimen, typically by needle aspiration of an abscess, fistula or sinus tract or from a large biopsy specimen. Due to the slow growing nature of the organism, cultures should be held for at least 14 days. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Definitive diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend high-dose penicillin as the treatment of choice for actinomycosis (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For mild infections, where significant suppuration or fistulous tracts are absent, we typically treat with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"       penicillin V",
"      </a>",
"      (2 to 4",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      in four divided daily doses) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      (500 mg three times daily) for two to six months. Acceptable alternatives to penicillins include the tetracyclines,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with more severe cervicofacial actinomycosis that require surgery, we typically treat with intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      (10 to 20 million units daily in divided doses every four to six hours) for four to six weeks, followed by oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"       penicillin V",
"      </a>",
"      (2 to 4 g per day in divided doses every six hours) for six to 12 months. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of therapy should be guided by the severity of infection and an ongoing assessment for clinical or pathologic remission. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For more complicated cases, surgical excision of recalcitrant fibrotic lesions or drainage of extensive abscesses with marsupilation of persisting sinus tracts is often required for definitive cure. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/1\">",
"      Kwartler JA, Limaye A. Pathologic quiz case 1. Cervicofacial actinomycosis. Arch Otolaryngol Head Neck Surg 1989; 115:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/2\">",
"      Brown JR. Human actinomycosis. A study of 181 subjects. Hum Pathol 1973; 4:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/3\">",
"      Lerner PI. The lumpy jaw. Cervicofacial actinomycosis. Infect Dis Clin North Am 1988; 2:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/4\">",
"      Israel, J. Neve beobactungen anf dem bebiete der mykosen des menshen. Virchows Arch Pathologische Anatomie 1878; 74:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/5\">",
"      Wolfe, M, Israel, J. Ueber reincultur des actinomyces and seine uebertragbarkeit auf thiere. Virchows Arch Pathologische Anatomie 1891; 126:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/6\">",
"      Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis 1998; 26:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/7\">",
"      Euz&eacute;by JP. List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol 1997; 47:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/8\">",
"      Schaal KP, Lee HJ. Actinomycete infections in humans--a review. Gene 1992; 115:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/9\">",
"      Lawson PA, Nikolaitchouk N, Falsen E, et al. Actinomyces funkei sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 2001; 51:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/10\">",
"      Nikolaitchouk N, Hoyles L, Falsen E, et al. Characterization of Actinomyces isolates from samples from the human urogenital tract: description of Actinomyces urogenitalis sp. nov. Int J Syst Evol Microbiol 2000; 50 Pt 4:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/11\">",
"      Funke G, von Graevenitz A. Infections due to Actinomyces neuii (former \"CDC coryneform group 1\" bacteria). Infection 1995; 23:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/12\">",
"      Belmont MJ, Behar PM, Wax MK. Atypical presentations of actinomycosis. Head Neck 1999; 21:264.",
"     </a>",
"    </li>",
"    <li>",
"     Jacobs, RF, Schutze, GE. Actinomycosis. In: Nelson Textbook of Pediatrics, 16th, Behrman, RE, (Eds), WB Saunders, Philadelphia 2000. p.823.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/14\">",
"      Holm, P. Studies on the aetiology of actinomycosis. I. The \"other\" microbes of actinomycosis and their importance. Acta Pathol Microbiol Scand 1950; 27:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/15\">",
"      HOLM P. Studies on the aetiology of human actinomycosis. II. Do the other microbes of actinomycosis possess virulence? Acta Pathol Microbiol Scand 1951; 28:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/16\">",
"      PINE L, OVERMAN JR. DETERMINATION OF THE STRUCTURE AND COMPOSITION OF THE 'SULPHUR GRANULES' OF ACTINOMYCES BOVIS. J Gen Microbiol 1963; 32:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/17\">",
"      Hotchi M, Schwarz J. Characterization of actinomycotic granules by architecture and staining methods. Arch Pathol 1972; 93:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/18\">",
"      Feder HM Jr. Actinomycosis manifesting as an acute painless lump of the jaw. Pediatrics 1990; 85:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/19\">",
"      Atespare A, Keskin G, Er&ccedil;in C, et al. Actinomycosis of the tongue: a diagnostic dilemma. J Laryngol Otol 2006; 120:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/20\">",
"      Burns BV, al-Ayoubi A, Ray J, et al. Actinomycosis of the posterior triangle: a case report and review of the literature. J Laryngol Otol 1997; 111:1082.",
"     </a>",
"    </li>",
"    <li>",
"     Schaal, KP, Beaman, BL. Clinical significance of actinomycetes. In: The Biology of the Actinomycetes, Goodfellow, M, Mordarski, M, Williams, ST, (Eds), Academic Press, New York 1983. p.389.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/22\">",
"      Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J 2003; 21:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/23\">",
"      Woo HJ, Bae CH, Song SY, et al. Actinomycosis of the paranasal sinus. Otolaryngol Head Neck Surg 2008; 139:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/24\">",
"      Kalioras V, Thanos L, Mylona S, et al. Scalp actinomycosis mimicking soft tissue mass. Dentomaxillofac Radiol 2006; 35:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/25\">",
"      Rankow RM, Abraham DM. Actinomycosis: masquerader in the head and neck. Ann Otol Rhinol Laryngol 1978; 87:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/26\">",
"      PEABODY JW Jr, SEABURY JH. Actinomycosis and nocardiosis. A review of basic differences in therapy. Am J Med 1960; 28:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/27\">",
"      Pollock PG, Meyers DS, Frable WJ, et al. Rapid diagnosis of actinomycosis by thin-needle aspiration biopsy. Am J Clin Pathol 1978; 70:27.",
"     </a>",
"    </li>",
"    <li>",
"     Lerner, PI. Serologic screening for actinomycosis. In: Anaerobic Bacteria: Role in Disease, Balows A (Eds), Charles C. Thomas, Springfield, IL 1974. p.571.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/29\">",
"      Martin MV. The use of oral amoxycillin for the treatment of actinomycosis. A clinical and in vitro study. Br Dent J 1984; 156:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/30\">",
"      SPILSBURY BW, JOHNSTONE FR. The clinical course of actinomycotic infections: a report of 14 cases. Can J Surg 1962; 5:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/31\">",
"      Nielsen, PM. Int J Oral Maxillofac Surg 1987; 156:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/32\">",
"      Gilbert, DN, Moellering Jr, RC, Sande, MA. The Sanford Guide to Antimicrobial Therapy 2001; 31:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/33\">",
"      Lerner PI. Susceptibility of pathogenic actinomycetes to antimicrobial compounds. Antimicrob Agents Chemother 1974; 5:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/34\">",
"      Martin MV. Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study. Br J Oral Maxillofac Surg 1985; 23:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/35\">",
"      Tanaka-Bandoh K, Watanabe K, Kato N, Ueno K. Susceptibilities of Actinomyces species and Propionibacterium propionicus to antimicrobial agents. Clin Infect Dis 1997; 25 Suppl 2:S262.",
"     </a>",
"    </li>",
"    <li>",
"     Smego Jr, RA. Actinomycosis. In: Infectious Diseases, Hoeprich, PD, Jordan, MC, Ronald, AR, (Eds), Lippincott Co, New York 1994. p.493.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21559/abstract/37\">",
"      Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope 1984; 94:1198.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3411 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-C1F21EE0D5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21559=[""].join("\n");
var outline_f21_3_21559=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Distinguishing features from fungi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Growth characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Infecting species",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Coinfecting organisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Sulfur granules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Predisposing conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pitfalls in the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Definitive diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Histology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Monoclonal antibody staining",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3411\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3411|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/19/34096\" title=\"figure 1\">",
"      Actinomyces sulfur granules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3411|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/40/40591\" title=\"picture 1\">",
"      Actinomyces israelii gram stain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38452?source=related_link\">",
"      Abdominal actinomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/53/20313?source=related_link\">",
"      Complications, diagnosis, and treatment of odontogenic infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36569?source=related_link\">",
"      Deep neck space infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=related_link\">",
"      Overview of intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29560?source=related_link\">",
"      Treatment of nocardiosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21560="MDMA (ecstasy) intoxication";
var content_f21_3_21560=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   MDMA (ecstasy) intoxication",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Robert J Hoffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21560/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/3/21560/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA (3,4-methylenedioxymethamphetamine, also called ecstasy) is a synthetic compound with structural and pharmacologic similarities to both amphetamines and mescaline. First developed in 1914 as an appetite suppressant, MDMA found use as a psychotherapeutic agent during the 1970s [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, its potential for abuse was quickly recognized, leading government agencies to place tight restrictions on its use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MDMA is a commonly abused drug, particularly among young party-goers at \"raves\" and \"circuit parties\" due to its capacity to elicit feelings of euphoria, wakefulness, intimacy, sexual arousal, and disinhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features and management of acute MDMA intoxication will be reviewed here. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef57745 \" href=\"UTD.htm?41/60/42956\">",
"     table 1",
"    </a>",
"    ). Detailed discussions of related issues, such as serotonin syndrome, severe hyperthermia, and a general discussion of the poisoned patient are found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=see_link\">",
"     \"Severe hyperthermia (heat stroke) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17436336\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abuse of MDMA fluctuates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In 1996, 5.7 percent of United States 12",
"    <sup>",
"     th",
"    </sup>",
"    grade students reported using MDMA, but in 2008 4.3 percent of 12",
"    <sup>",
"     th",
"    </sup>",
"    grade students did so. The number of younger users may be increasing; in 2008, 1.7 percent of United States 8",
"    <sup>",
"     th",
"    </sup>",
"    grade students admitted to having used MDMA. This may be due in part to the erroneous belief that MDMA provides a &ldquo;safe&rdquo; high. In fact, MDMA shares toxicities with amphetamine, in addition to unique adverse effects. Use among adults may be decreasing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA (3,4-methylenedioxymethamphetamine) is a sympathomimetic amphetamine that causes release of endogenous catecholamines (particularly norepinephrine and dopamine) and blocks their reuptake into presynaptic vesicles.",
"   </p>",
"   <p>",
"    MDMA differs somewhat from traditional amphetamines in that it is structurally similar to serotonin. This difference likely accounts for an increased release of serotonin and inhibition of serotonin reuptake [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/4,8,9\">",
"     4,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This results in a toxicity profile for MDMA that is different from that of traditional amphetamines. Although typical findings of amphetamine toxicity (hypertension, tachycardia, hyperthermia, CNS stimulation) are often seen in MDMA toxicity, serotonergic toxicity (serotonin syndrome, SIADH) may be seen as well.",
"   </p>",
"   <p>",
"    Over 100 congeners of MDMA exist. Tablets purported to contain MDMA may contain highly toxic MDMA analogs or completely different drugs altogether. In addition to amphetamine derivatives, numerous other compounds are abused in a manner similar to MDMA. Many are sold illicitly by internet vendors, and these substances are often misrepresented as MDMA and sold to unknowing users. Such substances include phenylethylamines 2CB, 2CT2, 2CT7, DOM, Bromo-dragonfly, and the tryptamines DMT, 5 Meo-DMT, and &ldquo;Foxy.&rdquo; The effects of these agents may be similar to MDMA, but they may have greater potency, causing more severe hallucinations, greater serotonergic activity, and more severe overall toxicity. Management is similar to that described below for MDMA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA (3,4-methylenedioxymethamphetamine) is typically ingested as a tablet in dosages ranging from 50 mg to 200 mg, and it is readily absorbed from the gastrointestinal tract. Peak effects occur within two hours of ingestion and typically last four to six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/9\">",
"     9",
"    </a>",
"    ]. Up to 75 percent of MDMA is excreted in the urine unchanged, while the remainder is primarily metabolized by the hepatic enzyme CYP2D6 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The concentrations of MDMA contained in illicitly produced pills vary widely [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/4\">",
"     4",
"    </a>",
"    ]. Major toxicity and death may occur after ingestion of a single tablet; ingestion of larger quantities carries greater risk of toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA (3,4-methylenedioxymethamphetamine) increases alertness, reduces fatigue, and leads to feelings of increased physical and mental powers, and euphoria. Users typically begin to experience the desired effects of MDMA approximately one hour following oral administration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/8\">",
"     8",
"    </a>",
"    ]. Minor adverse reactions, such as agitation, nausea, bruxism (grinding teeth), ataxia, diaphoresis, blurry vision, tachycardia, and hypertension, can also occur at typical MDMA doses. These effects are usually self-limited and resolve within hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/12\">",
"     12",
"    </a>",
"    ]. More serious effects are uncommon and described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA can cause hypertension, tachycardia, and hyperthermia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cardiovascular stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-threatening increases in heart rate and blood pressure may occur. Cardiovascular toxicity can include hypertensive emergencies, intracranial hemorrhage, myocardial infarction, aortic dissection, and dysrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/13-19\">",
"     13-19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hyperthermia and related effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthermia may result from drug effects on the central nervous system (CNS), prolonged physical exertion (eg, dancing all night at a \"rave\"), and environmental conditions (eg, dancing in a densely populated, hot room). Both the stimulant effect of amphetamines and serotonin syndrome may contribute to severe hyperthermia in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/17,20\">",
"     17,20",
"    </a>",
"    ]. Hyperthermia can lead to disseminated intravascular coagulation and rhabdomyolysis. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Hyperthermia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Manifestations of hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA use can lead to hyponatremia due to a marked increase in fluid intake and in some patients, persistent secretion of antidiuretic hormone that slows the rate of water excretion. The belief among some MDMA users that they can avoid hyperthermia by drinking large amounts of water is the reason for increased fluid intake in many cases. The mechanisms that lead to hyponatremia are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link&amp;anchor=H4659391#H4659391\">",
"     \"Causes of hyponatremia\", section on 'Ecstasy (MDMA) intoxication'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Marked and often acute reductions in serum sodium can lead to serious neurologic manifestations including confusion, seizures, cerebral edema, cerebral herniation, and death. The serum sodium in such patients is usually below 120",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (120",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Young women appear to be at increased risk for both symptomatic hyponatremia and residual neurologic injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=see_link&amp;anchor=H7#H7\">",
"     \"Manifestations of hyponatremia and hypernatremia\", section on 'Susceptibility of premenopausal women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Neurologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stimulation of the CNS is common and can manifest as agitation, hyperactivity, anxiety, and even delirium [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/20\">",
"     20",
"    </a>",
"    ]. Seizures and status epilepticus can occur. Psychomotor agitation may be associated with hyperthermia as well as rhabdomyolysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1222407\">",
"    <span class=\"h2\">",
"     Hepatotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatotoxicity caused by MDMA poisoning is well recognized. Even in the absence of severe hyperthermia or disseminated intravascular coagulation, hepatitis, centrilobular necrosis, and hepatic fibrosis may result from MDMA abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Clinical findings are similar to other forms of toxin-induced hepatic injury and may include jaundice, abdominal pain, and vomiting. Elevations of bilirubin, aspartate transaminase (AST), and alanine transaminase (ALT) may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serotonin syndrome findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serotonin syndrome is a potentially life-threatening condition characterized by the triad of autonomic dysfunction, abnormal neuromuscular activity, and altered mental status. MDMA use can cause serotonin syndrome, presumably via stimulation of massive serotonin release. Individuals who use MDMA in combination with selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), or other drugs that increase 5-HT1A receptor activity (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    , tryptophan, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    ) are at greater risk of developing serotonin syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other sympathomimetic drugs of abuse, such as cocaine, amphetamine, and methamphetamine, may present with a clinical syndrome that is indistinguishable from MDMA (3,4-methylenedioxymethamphetamine) toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=see_link\">",
"     \"Cocaine: Acute intoxication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link\">",
"     \"Methamphetamine intoxication\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anticholinergic toxicity can present with delirium, dilated pupils, hyperthermia, tachycardia, and hypertension. Skin findings are helpful in distinguishing the two syndromes: patients with anticholinergic toxicity generally present with reduced or absent sweating, whereas patients with MDMA toxicity are usually diaphoretic. The typical pattern of speech is also different for the two poisonings, frequently being clear but pressured for MDMA and resembling a \"mouthful of marbles\" with anticholinergic toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of altered mental status, such as hypoglycemia, electrolyte disorders, intracranial hemorrhage, and infection should be considered. In particular, patients with hyperthermia and alteration in mental status who do not have a history strongly suggestive of MDMA or other drug intoxication should undergo lumbar puncture to rule out a CNS infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory evaluation of the poisoned patient should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Electrocardiogram (ECG), to rule out conduction system poisoning by drugs that effect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients in whom significant toxicity related to use of MDMA (3,4-methylenedioxymethamphetamine) is suspected, the clinician should also obtain the following [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basic serum electrolytes; if hyponatremia is present, a serum osmolality is recommended",
"     </li>",
"     <li>",
"      Creatine kinase and urine myoglobin, to evaluate for rhabdomyolysis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Serum creatinine, to assess for renal injury",
"     </li>",
"     <li>",
"      Serum aminotransferase concentrations, to assess for hepatic injury",
"     </li>",
"     <li>",
"      Coagulation studies (ie, aPTT, PT, INR, platelet count, d-dimer), to assess for disseminated intravascular coagulation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although there are specific serum and urine assays for MDMA, we advise against the use of these assays to guide clinical management. A positive MDMA screening test cannot confirm that a patient's symptoms are the result of MDMA toxicity. A negative test can occur despite the presence of MDMA congeners, of which there are over 100. Such congeners may cause clinical symptoms that are indistinguishable from MDMA toxicity. Regardless of whether the inciting agent is MDMA or a related drug, management is identical and based solely on the patient's clinical status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general approach to any poisoned patient must always begin with stabilization of the airway, breathing, and circulation. General discussions of the basic facets of the management of poisonings are found separately. Detailed management of MDMA (3,4-methylenedioxymethamphetamine) intoxication and similar agents is discussed immediately below. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef57745 \" href=\"UTD.htm?41/60/42956\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=see_link\">",
"     \"Enhanced elimination of poisons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Initial resuscitation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Airway",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA-associated hyponatremia frequently produces obtundation to a degree that necessitates endotracheal intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/20,27\">",
"     20,27",
"    </a>",
"    ]. Standard agents for rapid sequence intubation (RSI) may be used. Prophylactic agents to prevent elevations in intracranial pressure during RSI are unnecessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of oxygenation are not expected with MDMA toxicity and should prompt consideration of another diagnosis or a separate concurrent problem (such as aspiration pneumonia).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypertension from sympathomimetic use typically has a central and peripheral component. Treatment of the central component is accomplished with sedatives; benzodiazepines (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    , 1 to 2 mg IV push; may repeat until hypertension is controlled or patient is sedated) are appropriate first line agents. Hypertension refractory to aggressive benzodiazepine therapy is not typical, but can be treated with peripheral agents, such as sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    (standard doses) or the alpha-adrenergic blocking agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34485?source=see_link\">",
"     phentolamine",
"    </a>",
"    (1 to 5 mg IV).",
"   </p>",
"   <p>",
"    Tachycardia alone, in the absence of hypertension, rarely requires treatment. In the unlikely event of a supraventricular tachycardia, adenosine or calcium channel blockers may be used.",
"   </p>",
"   <p>",
"    The use of beta-blocking agents to control pulse or blood pressure in sympathomimetic poisoning is controversial. Pure beta-blocking agents, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40536?source=see_link\">",
"     esmolol",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    , may lead to unopposed alpha-adrenergic stimulation, may exacerbate coronary artery vasospasm, and increase lethality in animal studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data relating to the use of the mixed",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    antagonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    is less clear. Proponents cite anecdotal data, and a small laboratory study that suggests labetalol is safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. Opponents emphasize that intravenous labetalol acts almost entirely as a beta blocking agent (ratio of beta to alpha blockade is 7:1), and increases mortality in an animal model of sympathomimetic poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/36-38\">",
"     36-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the availability of other antihypertensive agents and the controversy that surrounds this issue, we suggest against the use of all beta blocking agents, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    , in the treatment of hypertension associated with sympathomimetic poisoning. Otherwise, cardiac arrhythmias are managed according to current advanced cardiac life support (ACLS) protocols. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indiscriminate fluid resuscitation should be avoided, as it may cause or exacerbate MDMA-associated hyponatremia. In the event the patient truly appears hypovolemic (as demonstrated by poor skin turgor or dry mucous membranes), normal saline may be administered until euvolemia is obtained. Tachycardia is",
"    <strong>",
"     NOT",
"    </strong>",
"    an appropriate surrogate endpoint for dehydration, as many patients with MDMA toxicity are tachycardic due to the sympathomimetic effects of the drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For a recent ingestion (ie, less than one hour) of MDMA (3,4-methylenedioxymethamphetamine), a single dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (AC) (1",
"    <span class=\"nowrap\">",
"     g/kg;",
"    </span>",
"    maximum dose 50 g) should be administered. Beyond one hour, drug absorption is usually complete and decontamination is not indicated. However, if a coingestant is suspected, decontamination after one hour may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=see_link\">",
"     \"Enhanced elimination of poisons\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should not be performed solely for the purpose of giving charcoal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cardiac effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to hemodynamic effects (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Circulation'",
"    </a>",
"    above), MDMA may produce cardiac ischemia. An electrocardiogram (ECG) should therefore be obtained in all patients with MDMA intoxication and cardiovascular symptoms. Chest pain associated with MDMA use should be evaluated and managed in a manner similar to that of cocaine-associated chest pain. Benzodiazepines (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    , 1 to 2 mg IV, repeat as needed) are an appropriate initial therapy for blood pressure control and agitation.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    , and supplemental oxygen are all indicated. We recommend against the use of beta-blocking agents, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    . (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Circulation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Psychomotor agitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychomotor agitation should be treated with sedative medications. We prefer benzodiazepines as first-line agents, as they have an excellent safety profile and are readily available.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     Lorazepam",
"    </a>",
"    (1 to 2 mg IV) has a rapid onset of sedative effects; repeat doses may be administered until agitation is controlled. Very high doses of benzodiazepines (ie, greater than 10 mg of lorazepam) may be required.",
"   </p>",
"   <p>",
"    Butyrophenones (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    ) interfere with heat dissipation, may prolong the QTc, and may reduce the seizure threshold. Given that hyperthermia and seizures are known consequences of MDMA toxicity, we suggest that butyrophenones",
"    <strong>",
"     NOT",
"    </strong>",
"    be used.",
"   </p>",
"   <p>",
"    Minimizing stimuli, such as light and noise, is helpful. Physical restraint should be avoided, if possible, and should only be used until the patient can be chemically sedated. Antipsychotic agents are not indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accurate core body temperature should be obtained. Severe hyperthermia (temperature &gt;41&ordm;C; 107&ordm;F) can be managed by immersion in an ice bath, if feasible, until the core temperature is reduced to 100&ordm;F. The temperature may continue to drop slightly after exiting an ice bath, but this after-drop is typically mild. Moderate hyperthermia should be treated with other cooling measures, including cooling blankets and the combination of cool water mist with fanning. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=see_link\">",
"     \"Severe hyperthermia (heat stroke) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If hyperthermia from serotonin syndrome is suspected, initial treatment with benzodiazepines and possibly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    is appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21560/abstract/4,17\">",
"     4,17",
"    </a>",
"    ]. If hyperthermia is refractory to these measures, intubation and paralysis should be strongly considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic and usually mild hyponatremia can be treated with fluid restriction alone, which usually leads to resolution of the hyponatremia within 12 to 24 hours. However, as mentioned above, MDMA use may be associated with the development of severe hyponatremia that can lead to neurologic symptoms (eg, confusion, seizures), cerebral edema, brain herniation, and death. The serum sodium is usually less than 120",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (120",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of the treatment of hyponatremia\", section on 'Symptomatic versus asymptomatic hyponatremia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with marked neurologic symptoms should be treated initially with hypertonic saline (3 percent or 513",
"    <span class=\"nowrap\">",
"     meq/L).",
"    </span>",
"    One regimen that we have used was initially described in hyponatremic athletes participating in endurance events, such as marathon races, an acute form of hyponatremia similar to ecstasy intoxication. It consists of 100 mL of 3 percent saline given as an intravenous bolus, which should acutely raise the serum sodium concentration by 2 to 3",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    <span class=\"nowrap\">",
"     (mmol/L),",
"    </span>",
"    thereby reducing the degree of cerebral edema. If neurologic symptoms persist or worsen, a 100 mL bolus of 3 percent saline can be repeated one or two more times at 10 minute intervals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=see_link&amp;anchor=H19#H19\">",
"     \"Exercise-associated hyponatremia\", section on 'Use of hypertonic saline'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The serum sodium is monitored closely. Overly rapid correction in patients with marked hyponatremia for two days or more is associated with an increased risk of severe and often irreversible neurologic injury, called osmotic demyelination. However, patients with very acute hyponatremia, as occurs in ecstasy intoxication and exercise-associated hyponatremia, are at minimal risk for this complication. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of the treatment of hyponatremia\", section on 'Rate of correction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10074?source=see_link\">",
"     \"Osmotic demyelination syndrome and overly rapid correction of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures, whether or not they are associated with hyponatremia, are treated with benzodiazepines and (if necessary) appropriate correction of the patient's serum sodium as described in the preceding section. The mechanism of MDMA-induced seizures makes",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    an illogical treatment choice, and we do not recommend its use. Seizures that occur in the setting of drug intoxication typically result from an altered balance of excitatory and inhibitory neurotransmitters. This mechanism is distinct from that of patients with a known seizure disorder, who generally have electrical instability in a discrete area of brain tissue amenable to treatment with sodium channel blocking agents, such as phenytoin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Serotonin syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benzodiazepines, with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/25/19862?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    , remain the mainstay of treatment. Patients with significant hyperthermia as part of a severe serotonin syndrome require aggressive treatment. The management of serotonin syndrome is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe toxicity, including cardiotoxicity, hypertensive emergency, severe neurologic symptoms, hyperthermia, serotonin syndrome, and",
"    <span class=\"nowrap\">",
"     hyponatremia/hypoosmolality",
"    </span>",
"    should be managed in an intensive care setting. Patients with mild symptoms and no evidence of end-organ toxicity may be discharged after their symptoms resolve, usually within six to eight hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11632567\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDMA (3,4-methylenedioxymethamphetamine) continues to gain popularity as a drug of abuse, particularly among adolescent and young adults who attend all-night dance parties, sometimes referred to as \"raves\" or \"circuit parties,\" due to its capacity to elicit feelings of euphoria, wakefulness, intimacy, and disinhibition. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef57745 \" href=\"UTD.htm?41/60/42956\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Pharmacology and presentation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peak effects of MDMA toxicity occur within two hours of ingestion and typically last four to six hours. Concentrations of MDMA contained in illicitly produced pills vary widely. Major toxicity and death may occur after ingestion of a single tablet. Tablets purported to contain MDMA may contain highly toxic MDMA analogs or completely different drugs altogether. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pharmacology and cellular toxicology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Kinetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MDMA intoxication can cause a myriad of dangerous effects including severe hypertension, hyperthermia, delirium, psychomotor agitation, and profound hyponatremia. Potential life-threatening complications of these effects include intracranial hemorrhage, myocardial infarction, aortic dissection, disseminated intravascular coagulation, rhabdomyolysis, seizure, and serotonin syndrome. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis for MDMA intoxication includes other sympathomimetic drugs of abuse, such as cocaine, amphetamine, and methamphetamine, and anticholinergic toxicity. Hypoglycemia, electrolyte disorders, intracranial hemorrhage, and infection should also be considered. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with hyperthermia and alterations in mental status who do not have a history strongly suggestive of MDMA or other drug intoxication should undergo lumbar puncture to rule out an infection of the central nervous system (CNS). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Hyperthermia and related effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine laboratory evaluation of the poisoned patient should include the following (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory evaluation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fingerstick glucose",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels",
"     </li>",
"     <li>",
"      Electrocardiogram (ECG)",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients in whom significant toxicity related to use of MDMA is suspected, the clinician should also obtain the following (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory evaluation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Basic serum electrolytes; if hyponatremia is present, a serum osmolality is recommended",
"     </li>",
"     <li>",
"      Creatine kinase and urine myoglobin",
"     </li>",
"     <li>",
"      Serum creatinine",
"     </li>",
"     <li>",
"      Serum aminotransferase concentrations",
"     </li>",
"     <li>",
"      Coagulation studies (ie, aPTT, PT, INR, platelet count, d-dimer)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MDMA-associated hyponatremia frequently produces obtundation to a degree that necessitates endotracheal intubation. No induction or paralytic agent commonly used for rapid sequence intubation (RSI) is contraindicated in the setting of MDMA intoxication. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Initial resuscitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend severe hypertension and psychomotor agitation be treated with benzodiazepines (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      , 1 to 2 mg IV push; may repeat until hypertension is controlled or patient is sedated) (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Refractory hypertension may be treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"       nitroprusside",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34485?source=see_link\">",
"       phentolamine",
"      </a>",
"      . We avoid beta-blocking agents, including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"       labetalol",
"      </a>",
"      , in the treatment of sympathomimetic poisoning because they may lead to unopposed alpha-adrenergic stimulation and a paradoxical increase in blood pressure. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Psychomotor agitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For a recent ingestion (ie, less than one hour) of MDMA, we suggest a single dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       activated charcoal",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       g/kg;",
"      </span>",
"      maximum dose 50 g) be administered (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should not be performed solely for the purpose of giving charcoal. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Butyrophenones (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"       haloperidol",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      ) interfere with heat dissipation, may prolong the QTc, and may reduce the seizure threshold. We suggest butyrophenones",
"      <strong>",
"       NOT",
"      </strong>",
"      be used to sedate patients with MDMA toxicity (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Psychomotor agitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Seizures, hyperthermia, and serotonin syndrome should be treated in standard fashion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=see_link\">",
"       \"Status epilepticus in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=see_link\">",
"       \"Severe hyperthermia (heat stroke) in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"       \"Serotonin syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with severe symptomatic hyponatremia (serum sodium usually less than 120",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      or 120",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      we recommend treatment with hypertonic saline (3 percent or 513",
"      <span class=\"nowrap\">",
"       meq/L)",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). We use the following regimen: 100 mL of 3 percent saline given as an intravenous bolus, which should acutely raise the serum sodium concentration by 2 to 3",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      <span class=\"nowrap\">",
"       (mmol/L),",
"      </span>",
"      thereby reducing the degree of cerebral edema. If neurologic symptoms persist or worsen, a 100 mL bolus of 3 percent saline can be repeated one or two more times at 10 minute intervals. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Hyponatremia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with mild asymptomatic hyponatremia, we recommend fluid restriction alone (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). This generally results in the resolution of hyponatremia within 12 to 24 hours. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Hyponatremia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7645558\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author would like to acknowledge Dr. Liza Victoria Seno Escobedo for her contributions, particularly her review of the literature and assistance updating the current topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/1\">",
"      Christophersen AS. Amphetamine designer drugs - an overview and epidemiology. Toxicol Lett 2000; 112-113:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/2\">",
"      Shulgin AT. The background and chemistry of MDMA. J Psychoactive Drugs 1986; 18:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/3\">",
"      Rosenbaum M. Ecstasy: America's new \"reefer madness\". J Psychoactive Drugs 2002; 34:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/4\">",
"      Kalant H. The pharmacology and toxicology of \"ecstasy\" (MDMA) and related drugs. CMAJ 2001; 165:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/5\">",
"      Arria AM, Yacoubian GS Jr, Fost E, Wish ED. The pediatric forum: ecstasy use among club rave attendees. Arch Pediatr Adolesc Med 2002; 156:295.",
"     </a>",
"    </li>",
"    <li>",
"     Johnston, LD, O'Malley, PM, Bachman, JG. Monitoring the future: national results on adolescent drug use: overview of key findings 2001. National Institutes of Health, Publication no. 02-5105, National Institute on Drug Abuse, Bethesda 2001.",
"    </li>",
"    <li>",
"     Johnston, LD, O'Malley, PM, Bachman, JG, Schulenberg, JE. Monitoring the future: national results on drug use: 1975-2008. National Institutes of Health, Publication no. 09-7403, National Institute on Drug Abuse, Bethesda 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/8\">",
"      Rochester JA, Kirchner JT. Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology. J Am Board Fam Pract 1999; 12:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/9\">",
"      Shannon M. Methylenedioxymethamphetamine (MDMA, \"Ecstasy\"). Pediatr Emerg Care 2000; 16:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/10\">",
"      Colado MI, Williams JL, Green AR. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 1995; 115:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/11\">",
"      Wu D, Otton SV, Inaba T, et al. Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol 1997; 53:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/12\">",
"      Thompson JP. Acute effects of drugs of abuse. Clin Med 2003; 3:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/13\">",
"      Lai TI, Hwang JJ, Fang CC, Chen WJ. Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction. Ann Emerg Med 2003; 42:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/14\">",
"      Mas M, Farr&eacute; M, de la Torre R, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999; 290:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/15\">",
"      Caballero F, Lopez-Navidad A, Cotorruelo J, Txoperena G. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation. Transplantation 2002; 74:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/16\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2001. A 17-year-old girl with marked jaundice and weight loss. N Engl J Med 2001; 344:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/17\">",
"      Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med 1994; 24:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/18\">",
"      Madhok A, Boxer R, Chowdhury D. Atrial fibrillation in an adolescent--the agony of ecstasy. Pediatr Emerg Care 2003; 19:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/19\">",
"      Duflou J, Mark A. Aortic dissection after ingestion of \"ecstasy\" (MDMA). Am J Forensic Med Pathol 2000; 21:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/20\">",
"      Williams H, Dratcu L, Taylor R, et al. \"Saturday night fever\": ecstasy related problems in a London accident and emergency department. J Accid Emerg Med 1998; 15:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/21\">",
"      Carvalho M, Pontes H, Remi&atilde;o F, et al. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 2010; 11:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/22\">",
"      Andreu V, Mas A, Bruguera M, et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998; 29:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/23\">",
"      Mueller PD, Korey WS. Death by \"ecstasy\": the serotonin syndrome? Ann Emerg Med 1998; 32:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/24\">",
"      Martin TG. Serotonin syndrome. Ann Emerg Med 1996; 28:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/25\">",
"      Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/26\">",
"      Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995; 45:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/27\">",
"      Hartung TK, Schofield E, Short AI, et al. Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion. QJM 2002; 95:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/28\">",
"      Pollan S, Tadjziechy M. Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity. Anesth Analg 1989; 69:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/29\">",
"      Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 1991; 9:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/30\">",
"      Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990; 112:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/31\">",
"      Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 1981; 217:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/32\">",
"      Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med 1988; 17:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/33\">",
"      Gay GR, Loper KA. Control of cocaine-induced hypertension with labetalol. Anesth Analg 1988; 67:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/34\">",
"      Mariani PJ. Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. Am J Emerg Med 1986; 4:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/35\">",
"      Sofuoglu M, Brown S, Babb DA, et al. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav 2000; 65:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/36\">",
"      Smith M, Garner D, Niemann JT. Pharmacologic interventions after an LD50 cocaine insult in a chronically instrumented rat model: are beta-blockers contraindicated? Ann Emerg Med 1991; 20:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/37\">",
"      Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993; 94:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21560/abstract/38\">",
"      Richards DA, Prichard BN, Boakes AJ, et al. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J 1977; 39:99.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 302 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-82D89F4E57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21560=[""].join("\n");
var outline_f21_3_21560=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17436336\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vital signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cardiovascular stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hyperthermia and related effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Manifestations of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Neurologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1222407\">",
"      Hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serotonin syndrome findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Initial resuscitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Airway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Breathing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cardiac effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Psychomotor agitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11632567\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Pharmacology and presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7645558\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/302\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/302|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/60/42956\" title=\"table 1\">",
"      MDMA-ecstasy-intoxication - Rapid overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=related_link\">",
"      Causes of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=related_link\">",
"      Enhanced elimination of poisons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=related_link\">",
"      Exercise-associated hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=related_link\">",
"      Manifestations of hyponatremia and hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=related_link\">",
"      Methamphetamine intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10074?source=related_link\">",
"      Osmotic demyelination syndrome and overly rapid correction of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=related_link\">",
"      Overview of the treatment of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=related_link\">",
"      Severe hyperthermia (heat stroke) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21561="Overview of inguinal hernia in children";
var content_f21_3_21561=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of inguinal hernia in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Chris Ramsook, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Erin E Endom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Jonathan I Singer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/3/21561/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/3/21561/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/3/21561/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary inguinal hernia occurs in 1 to 5 percent of all newborns and 9 to 11 percent of those born prematurely [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/1\">",
"     1",
"    </a>",
"    ]. Inguinal hernia repair is the most commonly performed surgical procedure in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ]. Most children with an inguinal hernia have minimal symptoms. The diagnosis is usually made easily and the repair generally is uncomplicated. Strangulation can be avoided when incarceration is promptly recognized and treated.",
"   </p>",
"   <p>",
"    The epidemiology, clinical presentation, and management of inguinal hernia in children will be reviewed here.",
"   </p>",
"   <p>",
"    The evaluation of inguinal swelling and the causes and evaluation of scrotal pain and swelling in children and adolescents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=see_link\">",
"     \"Evaluation of inguinal swelling in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=see_link\">",
"     \"Causes of painless scrotal swelling in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link\">",
"     \"Causes of scrotal pain in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2663?source=see_link\">",
"     \"Evaluation of scrotal pain or swelling in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hydrocele",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hydrocele is a fluid-filled collection that can occur anywhere along the path of descent of the testis or ovary (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Embryology'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hernia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hernia is the protrusion of a portion of an organ or tissue through an abnormal opening in the wall that normally contains it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Incarceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incarceration describes a hernia that cannot be reduced by manipulation. An incarcerated hernia may or may not be strangulated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Strangulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strangulation refers to vascular compromise of the contents of an incarcerated hernia, caused by progressive edema from venous and lymphatic obstruction. Strangulation can occur within two hours of incarceration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ]. Prolonged strangulation may rarely lead to necrosis and, in the case of bowel, perforation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EMBRYOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Testes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The testes appear on the ventromedial aspect of the urogenital ridge on the posterior abdominal wall during the fifth to sixth week of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ]. By the tenth week, they have descended through the coelomic cavity and can be found close to the groin. The processus vaginalis forms during the third month of gestation from an outward protrusion of the peritoneum that lines the ventral abdominal wall and forms a diverticulum at the internal ring (",
"    <a class=\"graphic graphic_figure graphicRef78798 \" href=\"UTD.htm?16/4/16453\">",
"     figure 1",
"    </a>",
"    ). Between the seventh and ninth months of gestation, the testes descend through the internal canal and into the scrotum, pushing the processus vaginalis ahead and protruding into its cavity. Once this process is complete, the processus vaginalis obliterates spontaneously, usually by age two years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ovaries",
"    </span>",
"    &nbsp;&mdash;&nbsp;The descent of the ovaries is similar to that of the testes except that the ovaries do not leave the abdominal cavity. The diverticulum of Nuck in girls corresponds to the processus vaginalis in boys and is a pocket of peritoneum that extends from the uterus to the labia majora. It normally closes spontaneously at about seven month&rsquo;s gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The closure of the processus vaginalis may be hindered by the persistence of smooth muscle. Myofibroblasts, thought to represent dedifferentiation of smooth muscle and failed apoptosis, were found by electron microscopy in all inguinal hernia sac specimens of 20 children (10 boys and 10 girls) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inguinal canal is an oblique channel through the abdominal wall through which the spermatic cord passes from the abdomen into the scrotum in boys and the round ligament passes from the abdomen into the labia majora in girls. It is formed by the aponeurosis of the external oblique muscle (anteriorly) and the transversus abdominus muscle and the transversalis fascia (posteriorly) (",
"    <a class=\"graphic graphic_figure graphicRef60403 graphicRef57672 \" href=\"UTD.htm?9/38/9834\">",
"     figure 2A-B",
"    </a>",
"    ). Hesselbach's triangle, bounded by the inferior epigastric vessels, the inguinal ligament, and the rectus sheath, is an area of the posterior wall at particular risk for direct herniation.",
"   </p>",
"   <p>",
"    The external inguinal ring is formed by the external oblique muscle just superior and lateral to the pubic tubercle. The internal inguinal ring is located in the transversalis fascia and composed of the transversus abdominus and internal oblique muscles (",
"    <a class=\"graphic graphic_figure graphicRef57672 \" href=\"UTD.htm?14/35/14898\">",
"     figure 2B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In infants, the inguinal canal is short and crosses the abdominal wall perpendicularly rather than obliquely so that the external ring is situated almost directly over the internal ring [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2,6\">",
"     2,6",
"    </a>",
"    ]. This anatomic alignment places infants at particular risk for development of inguinal hernia, especially premature infants in whom intraabdominal pressure may be increased by mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Various types of inguinal hernias and hydroceles may occur depending on where and to what degree the processus vaginalis becomes obliterated. This is illustrated in the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A widely patent processus vaginalis that permits herniation of the bowel through the internal inguinal ring results in an indirect inguinal hernia (",
"      <a class=\"graphic graphic_figure graphicRef67349 graphicRef82091 \" href=\"UTD.htm?9/9/9367\">",
"       figure 3A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A narrowly patent processus vaginalis that only permits passage of peritoneal fluid results in a communicating hydrocele (",
"      <a class=\"graphic graphic_figure graphicRef70784 \" href=\"UTD.htm?0/16/256\">",
"       figure 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A hydrocele of the cord occurs when the processus vaginalis is obliterated proximally and distally, but remains patent in the midportion along the spermatic cord.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The hernia sac generally contains peritoneal fluid (as in a communicating hydrocele) or bowel. In girls, the ovary is commonly involved. Hernias containing fallopian tube and uterus have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indirect inguinal hernias, the most common type in children, pass lateral to the deep epigastric vessels through the inguinal canal (",
"    <a class=\"graphic graphic_figure graphicRef67349 graphicRef82091 \" href=\"UTD.htm?9/9/9367\">",
"     figure 3A-B",
"    </a>",
"    ). Direct inguinal hernias are medial and inferior to the deep epigastric vessels and do not go through the inguinal canal (",
"    <a class=\"graphic graphic_figure graphicRef51224 \" href=\"UTD.htm?23/31/24050\">",
"     figure 5",
"    </a>",
"    ). Direct inguinal hernias are rare in children and usually follow an indirect inguinal hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/11\">",
"     11",
"    </a>",
"    ]. Femoral hernias, below the inguinal ligament and medial to the femoral artery (",
"    <a class=\"graphic graphic_figure graphicRef63036 \" href=\"UTD.htm?13/13/13523\">",
"     figure 6",
"    </a>",
"    ), also are rare in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary inguinal hernia occurs in 1 to 5 percent of all newborns and 9 to 11 percent of those born prematurely [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/1\">",
"     1",
"    </a>",
"    ]. Among low- and very low-birth-weight infants, the incidence of inguinal hernia varies by birth weight as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      500 to 1000 g &ndash; 30 to 42 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      1000 to 1500 g &ndash; 10 percent",
"     </li>",
"     <li>",
"      1500 to 2000 g &ndash; 3 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence is highest during the first year of life and peaks during the first month [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence in boys is three to four times higher than in girls, with the right side being affected more commonly in both sexes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16\">",
"     16",
"    </a>",
"    ]. The right-sided preponderance is related to the later descent of the right testicle and later obliteration of the processus vaginalis. The incidence of bilateral hernias is approximately 10 percent in full-term and nearly 50 percent in premature and low-birth-weight infants [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Incarceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of incarceration ranges from 14 to 31 percent, usually occurring in infants younger than one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Among children with incarcerated inguinal hernias, as many as 85 percent occur before the first birthday.",
"   </p>",
"   <p>",
"    Incarceration is the presenting sign of the hernia in as many as 65 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/21\">",
"     21",
"    </a>",
"    ]. It occurs more frequently in right-sided hernias as compared with left-sided ones (17 versus 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16,22\">",
"     16,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Incarceration occurs more frequently in girls compared with boys (17.2 versus 12 percent). In girls, when incarceration occurs, an ovary, rather than intestine, is typically involved.",
"   </p>",
"   <p>",
"    Some authors describe an increased incidence of incarceration in preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16,22\">",
"     16,22",
"    </a>",
"    ]. However, one review of inguinal hernia in 251 infants younger than six months, including 89 preterm infants, found that incarceration was less common in preterm than in term infants (13 versus 24 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Associated conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inguinal hernias are more common in children with abdominal wall defects (eg, Eagle-Barrett [prune belly] syndrome), conditions that increase intraabdominal pressure (eg, continuous ambulatory peritoneal dialysis, ventriculoperitoneal shunts, ascites, chronic respiratory disease), connective tissue disease (eg, Ehlers-Danlos syndrome), abnormalities of the genitourinary system (eg, ambiguous genitalia, hypospadias, bladder exstrophy, cryptorchid testis), or a family history of inguinal hernia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16,23\">",
"     16,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/23/44407?source=see_link\">",
"     \"Prune-belly syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=see_link\">",
"     \"Clinical manifestations and initial management of infants with bladder exstrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17098?source=see_link\">",
"     \"Undescended testes (cryptorchidism) in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete androgen insensitivity should be suspected in phenotypically normal female infants or children who have inguinal hernias or inguinal or labial masses. As many as 1 to 2 percent of girls with inguinal hernias may have this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In a survey of androgen insensitivity diagnosis and management in the United Kingdom, inguinal hernia was the presenting complaint in 22 of 29 (76 percent) and was present in 28 of 29 (96 percent) phenotypically female children with complete androgen insensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17096?source=see_link\">",
"     \"Diagnosis and treatment of disorders of the androgen receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with an inguinal hernia may present with clinical features that include history of an intermittent mass, a mass that is reducible, or incarceration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     No mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with an inguinal hernia have a history of an intermittent bulge in the groin that may have been noted at times of increased intraabdominal pressure, such as straining or crying [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ]. They are usually asymptomatic when this occurs.",
"   </p>",
"   <p>",
"    An inguinal mass is frequently not present on examination. Maneuvers to increase intraabdominal pressure and demonstrate the hernia are often unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/27\">",
"     27",
"    </a>",
"    ]. The \"silk sign\" is a palpable silky thickening of the cord that may sometimes be appreciated by placing a single finger parallel to the inguinal canal at the level of the pubic tubercle and rubbing it from side to side. This is not a reliable finding, however [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2,16\">",
"     2,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Reducible mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Often, families seek medical care because an inguinal mass has developed that has not spontaneously reduced. Nonspecific symptoms such as irritability and decreased appetite may be reported. The inguinal mass can extend into the scrotum. It should not be tender on examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Incarcerated mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with an incarcerated inguinal hernia usually are irritable and crying. Vomiting and abdominal distention may develop, depending on the duration of incarceration and whether or not intestinal obstruction has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical examination of children with incarcerated inguinal hernias usually is diagnostic. A firm, discrete inguinal mass, which may extend to the scrotum or labia majora, can be palpated in the groin. The mass usually is tender and often is surrounded by edema with erythema of the overlying skin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/20\">",
"     20",
"    </a>",
"    ]. The testicle may appear dark blue because of venous congestion caused by pressure on the spermatic cord.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes and diagnostic approach to inguinal swelling, including inguinal hernias, are discussed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef83582 \" href=\"UTD.htm?24/2/24619\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=see_link&amp;anchor=H7223760#H7223760\">",
"     \"Evaluation of inguinal swelling in children\", section on 'Causes of inguinal swelling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=see_link&amp;anchor=H7223842#H7223842\">",
"     \"Evaluation of inguinal swelling in children\", section on 'Approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some scrotal conditions may cause swelling that extends up into the external inguinal ring and appear similar to inguinal hernias. These include the following (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=see_link\">",
"     \"Causes of painless scrotal swelling in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link\">",
"     \"Causes of scrotal pain in children and adolescents\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hydrocele",
"      </strong>",
"      &ndash; An acute hydrocele generally involves only the scrotum; no mass is palpated in the area of the internal ring. This is in contrast to a communicating hydrocele, which is, in fact, a hernia containing peritoneal fluid (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Anatomy'",
"      </a>",
"      above). Hydroceles transilluminate and usually are cystic, irreducible, and nontender. An acute hydrocele of the spermatic cord may occasionally be difficult to distinguish from an incarcerated inguinal hernia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=see_link&amp;anchor=H2#H2\">",
"       \"Causes of painless scrotal swelling in children and adolescents\", section on 'Hydrocele'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Varicocele",
"      </strong>",
"      &ndash; Varicoceles, typically seen in the adolescent age group, are dilated veins of the pampiniform plexus of the spermatic cord. They usually increase with the Valsalva maneuver to produce a large, soft scrotal mass (\"bag of worms\") that decompresses in the recumbent position. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=see_link&amp;anchor=H7#H7\">",
"       \"Causes of painless scrotal swelling in children and adolescents\", section on 'Varicocele'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Testicular torsion",
"      </strong>",
"      &ndash; Testicular torsion causes severe pain and vomiting. The affected testicle is typically swollen, tender, and retracted toward the external ring. The cremasteric reflex is absent on the affected side. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link&amp;anchor=H2#H2\">",
"       \"Causes of scrotal pain in children and adolescents\", section on 'Testicular torsion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Torsion of the appendix testis",
"      </strong>",
"      &ndash; Torsion of the appendix testis produces a tender nodule on the upper pole of the testicle that may appear as a blue dot once the torsed tissue has become necrotic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link&amp;anchor=H9#H9\">",
"       \"Causes of scrotal pain in children and adolescents\", section on 'Torsion of the appendix testis or appendix epididymis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Retractile testis",
"      </strong>",
"      &ndash; An inguinal mass may represent a retractile testis that has moved into the inguinal canal as a result of an exaggerated cremasteric reflex. It can be distinguished from an inguinal hernia by bringing the testis into the scrotum. A finger is then placed transversely across the top of the scrotum at the base of the penis. This will prevent a retractile testis from ascending into the inguinal canal when the cremasteric reflex is again elicited [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"       2",
"      </a>",
"      ]. In addition, an empty hemi-scrotal sac suggests an abnormal testicular location. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=see_link&amp;anchor=H11662534#H11662534\">",
"       \"Evaluation of inguinal swelling in children\", section on 'Testicular dislocation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=see_link&amp;anchor=H11662518#H11662518\">",
"       \"Evaluation of inguinal swelling in children\", section on 'Testes: retractile, ectopic, or undescended'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Testicular cancer",
"      </strong>",
"      &ndash; Testicular cancer usually presents as a painless mass discovered by the patient or clinician on physical examination, although rapidly growing germ cell tumors may cause acute scrotal pain secondary to hemorrhage and infarction. Other common signs are testicular enlargement or swelling. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=see_link&amp;anchor=H11#H11\">",
"       \"Causes of painless scrotal swelling in children and adolescents\", section on 'Testicular cancer'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain abdominal radiographs are of limited use in the evaluation of a patient with an incarcerated hernia. An ultrasound examination may be helpful when the etiology of an acute groin swelling cannot be determined on clinical examination. The reported diagnostic accuracy of ultrasound is 93 percent for acute groin conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory work is not helpful in the evaluation of patients with hernias. One study reported white blood cell counts of 4600 to 21,000",
"    <span class=\"nowrap\">",
"     cells/&micro;L",
"    </span>",
"    (4.6 to 21.0 x",
"    <span class=\"nowrap\">",
"     10(9)/L)",
"    </span>",
"    in 69 children with incarcerated hernias and found no correlation between the white blood cell count and the degree of vascular compromise of the entrapped bowel described at surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Karyotyping should be considered when a testicle is palpable in the inguinal canal or found at herniorrhaphy in phenotypic females, since there is an association between androgen insensitivity and inguinal hernia (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Associated conditions'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitive management of inguinal hernia is surgical repair. Referral to a surgeon and the timing of the repair depend on whether or not the hernia is reducible. In addition, incarcerated hernias must be reduced as quickly as possible to avoid strangulation of the contents of the hernia sac.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     No mass, reducible mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;A convincing history of intermittent groin swelling or a reducible inguinal mass are indications for referral to a surgeon. Consultation should be obtained promptly but is not emergent. Once the diagnosis is made, however, repair should be performed soon to avoid complications, such as incarceration. Incarceration has been reported in as many as 13 percent of children awaiting elective repair, with the majority of cases in those less than one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/21,29,30\">",
"     21,29,30",
"    </a>",
"    ]. While awaiting surgical evaluation, caretakers should be informed of the signs and symptoms of incarceration and provided with indications for seeking medical attention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Inguinal mass in a female",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hernias in females are caused by the persistence of the diverticulum of Nuck and contain the suspensory ligament of the ovary [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. &nbsp;A significant number of these hernias also contain the ovary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fallopian tube [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/31\">",
"     31",
"    </a>",
"    ]. Rarely, the uterus may also be present [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/32\">",
"     32",
"    </a>",
"    ]. In one small series of 71 girls with an incarcerated painful mass in the inguinal canal, an ovary was found in 82 percent and a torsed ovary was found in 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/33\">",
"     33",
"    </a>",
"    ]. Because of the significant likelihood that reproductive organs are within the hernial sac, the clinician should attempt a gentle reduction and then obtain an ultrasound (US) if",
"    <strong>",
"     not",
"    </strong>",
"    successful. If the US indicates that reproductive organs are not present, then further efforts at reduction are appropriate. In patients in whom an incarcerated ovary is suspected, ultrasound first, if available, is an alternative approach. Ultrasound examination of the hernial sac is also helpful in identifying the contents prior to surgical repair of irreducible inguinal masses in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Incarcerated inguinal hernia",
"    </span>",
"    &nbsp;&mdash;&nbsp;An incarcerated inguinal hernia must be emergently reduced, either manually or surgically. Once the diagnosis has been made, children should have nothing by mouth, since emergent surgery may be required to reduce the hernia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Manual reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unless the child appears extremely ill and has signs of peritonitis, intestinal obstruction, or toxicity from gangrenous bowel, manual reduction should be attempted. Manual reduction is successful in 95 to 100 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/19,34-36\">",
"     19,34-36",
"    </a>",
"    ]. Elective repair after successful manual reduction has a lower complication rate than emergent operative reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Success rates for manual reduction are influenced by the duration of incarceration and the age of the child. In one report of 85 children younger than two years, those with failed, compared with successful, manual reductions were younger (three versus five months) and had longer duration of symptoms (34 versus 12 hours) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A survey of pediatric surgeons revealed that 95 percent used gentle manipulation to reduce incarcerated inguinal hernias. In addition to manipulation, 75 percent used sedation, 55 percent used elevation, and 18 percent applied ice packs to the inguinal area [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One technique of manual reduction of incarcerated inguinal hernias is as follows (",
"    <a class=\"graphic graphic_figure graphicRef53146 \" href=\"UTD.htm?25/45/26327\">",
"     figure 7",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pressure is applied along the proximal inguinal canal with one hand, while the other hand attempts to \"milk\" the gas or contents out of the incarcerated bowel with gentle pressure, for up to five minutes.",
"     </li>",
"     <li>",
"      After reducing the contents of the incarcerated bowel, pressure should be slightly increased over the distal aspect of the hernia to reduce the bowel.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternatively, the practitioner sweeps along the inguinal hernia into the scrotum and applies longitudinal tension, while providing traction that opens the internal and external hernial rings (",
"    <a class=\"graphic graphic_figure graphicRef62707 \" href=\"UTD.htm?26/48/27398\">",
"     figure 8",
"    </a>",
"    ). The hernia is then walked through the opening.",
"   </p>",
"   <p>",
"    If the above steps are not successful, a surgeon should be consulted. Most authorities would then recommend sedation with a narcotic such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    , Trendelenburg positioning, and an ice pack to the groin, followed by another attempt at manual reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/39\">",
"     39",
"    </a>",
"    ]. Up to 40 minutes of continuous pressure may be necessary to achieve reduction.",
"   </p>",
"   <p>",
"    Attempts at manual reduction of a prolapsed ovary are painful and should be performed only with sedation. In addition, torsion of the ovary within the hernia sac can occur. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The timing of repair after reduction of a hernia is discussed below. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Timing of repair'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Surgical reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the small percentage of cases where manual reduction is not successful, the hernia must be reduced surgically. Repair is generally performed at that time. A small observational series has described success using a laparoscopic approach for the reduction and repair of incarcerated inguinal hernias in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Surgical repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following procedures may be used for the repair of inguinal hernias in children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High ligation and excision of the processus vaginalis, the most common procedure, is used when the hernia is small and of recent onset. In girls, confirmation that the hernia sac does not contain the ovary, fallopian tube, or uterus is necessary before it is ligated [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to ligation and excision, plication of the floor of the inguinal canal (the transversalis fascia) may be necessary when the inguinal ring has been enlarged by repetitive herniation.",
"     </li>",
"     <li>",
"      Complete reconstruction of the floor of the inguinal canal using the conjoint tendon is occasionally required in small infants who have large hernias that have gone untreated, causing progressive enlargement of the inguinal ring and total breakdown of the transversalis fascia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Laparoscopic herniorrhaphy has been performed for many patients with good results [",
"      <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/43-46\">",
"       43-46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Boys who have an associated undescended testis should have orchidopexy at the same time as inguinal hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/2,16,41\">",
"     2,16,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Timing of repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the methods of repair are standard, the optimal timing is debatable. Immediate surgical repair after successful manual reduction of incarceration eliminates the risk of repeated incarceration. However, if performed immediately, the repair can be technically difficult, increasing the risk for development of a direct hernia as a complication. In addition, tissue swelling after incarceration can cause distortion of the anatomic landmarks, rendering detection of a coincident direct hernia difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/47\">",
"     47",
"    </a>",
"    ]. On the other hand, a delay in definitive repair carries the risk of recurrent incarceration and the need for emergent surgery. Risk of recurrent incarceration is between 16 and 35 percent, with the second episode occurring at a range of 0.5 to 120 days after the initial incarceration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/21,35\">",
"     21,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many pediatric surgeons hospitalize children after successful manual reduction of incarcerated inguinal hernia and repair the hernia within 24 to 48 hours. The short delay allows the involved tissues to return to their normal texture before surgery. To minimize the risk of recurrence, definitive hernia repair should be performed within five days (within two days for infants born prematurely) of the manual reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children with asymptomatic inguinal hernias, longer waiting time for elective surgery is also associated with increased risk for incarceration, especially in infants less than one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/21,29,30,48\">",
"     21,29,30,48",
"    </a>",
"    ]. An observational study from Canada found that a wait time for surgery that exceeded 14 days from the time of diagnosis in a physician's office was associated with an absolute increase of 7 percent (5 versus 12 percent) in the occurrence of incarceration in infants and young children (&lt;1 year of age) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/30\">",
"     30",
"    </a>",
"    ]. This finding suggests that a waiting time less than 14 days is advisable for asymptomatic inguinal hernias in this pediatric age group.",
"   </p>",
"   <p>",
"    Approximately one-third of preterm infants with birth weight less than 1000 g have inguinal hernias. These infants can be observed in the neonatal intensive care unit as long as the hernias are reducible. The hernias may be repaired before discharge from the intensive care unit once the infants weigh more than 1800 to 2000 g. Preterm infants who are at risk for apnea and bradycardia should be monitored closely in the postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/17,49\">",
"     17,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Contralateral exploration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for contralateral inguinal exploration also is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/48\">",
"     48",
"    </a>",
"    ]. The natural history of a patent processus vaginalis is closure within two months after birth in 40 percent and within two years in an additional 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/18\">",
"     18",
"    </a>",
"    ]. Of the remaining 40 percent, clinical hernias may develop in one-half, so the finding of a patent processus vaginalis in the absence of a clinical hernia is not a clear indicator of a future hernia.",
"   </p>",
"   <p>",
"    Although routine contralateral exploration had been a common practice, surveys of members of the American Academy of Pediatrics Section on Surgery conducted in 1993 and 2003 noted that the number of respondents who routinely explore the contralateral groin of boys less than two years of age declined from 65 percent to 44 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Similarly, routine contralateral exploration of girls less than four years dropped from 84 percent to 47 percent.",
"   </p>",
"   <p>",
"    This decline in routine contralateral exploration is supported by data from large prospective studies and a meta-analysis of children with unilateral inguinal hernia that identify an overall risk of metachronous hernia between 5 and 12 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/51-54\">",
"     51-54",
"    </a>",
"    ]. These reports all concluded that the low incidence of contralateral hernia did not justify routine exploration. One report noted that the risk of metachronous hernia was higher in premature infants (15 percent) and those with incarceration (28 percent) and suggested that contralateral exploration may be advisable in these children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/51\">",
"     51",
"    </a>",
"    ]. Also, children at particular risk for metachronous inguinal hernia, including those with ventriculoperitoneal shunts, increased intraabdominal pressure, connective tissue disease, or chronic pulmonary disease, should always undergo contralateral exploration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/16,41\">",
"     16,41",
"    </a>",
"    ], as should those who have an underlying medical condition that increases the risk of anesthetic complications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, the risks and benefits of open contralateral exploration for each child must be weighed individually. The risks of open contralateral exploration include damage to the spermatic cord, testis, or vas deferens in boys and damage to the ovary in girls. The benefit of contralateral exploration and repair of patent processus vaginalis or diverticulum of Nuck is the elimination of risk of future incarceration and the need for subsequent surgery.",
"   </p>",
"   <p>",
"    Transinguinal laparoscopic evaluation of the contralateral side during ipsilateral repair has been suggested as an alternative to open surgical exploration and leads to successful visualization of the contralateral inguinal ring in up to 97 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. This technique has a sensitivity of 99.4 percent and a specificity of 99.5 percent for detecting a patent processus vaginalis and can be performed with a mean operative time of six to eight minutes with a complication rate under one percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/56-58\">",
"     56-58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children who undergo repair of inguinal hernia have an uncomplicated postoperative course. Scrotal edema can occur as a postoperative complication; it usually resolves spontaneously over approximately three weeks. Postoperative hematomas and hydroceles, on the other hand, can take up to three months to resolve and should be followed to resolution by the operating surgeon. Postoperative infection occurs with a frequency of less than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel infarction, as a result of strangulation, is the most serious complication of an inguinal hernia. Infarction may occur within two hours of incarceration. Despite the fact that incarceration is not uncommon (particularly in young infants), the need for intestinal resection is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/19,22\">",
"     19,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Incarceration of an inguinal hernia can compromise the blood supply to the testis, resulting in ischemic necrosis and atrophy. Incidences of testicular atrophy from 2 to 9 percent have been reported after emergent operative reduction of incarceration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/19,59\">",
"     19,59",
"    </a>",
"    ]. Boys with inguinal hernias also can have injury to the vas deferens, with the development of sperm agglutinating antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In girls with incarcerated inguinal hernia, torsion rather than direct compression compromises the blood supply to the ovary. Strangulation is reported to occur in between 2 and 33 percent of girls with inguinal hernias with an irreducible ovary. Because torsion can occur in an irreducible ovary while awaiting elective inguinal hernia repair, some surgeons recommend immediate reduction and repair [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After surgical repair of an inguinal hernia, a risk of recurrence, ranging up to 6 percent and occurring at various times after the initial repair, exists [",
"    <a class=\"abstract\" href=\"UTD.htm?21/3/21561/abstract/47,63,64\">",
"     47,63,64",
"    </a>",
"    ]. Risk factors associated with recurrence include elevated intraabdominal pressure (ventriculoperitoneal shunt, cystic fibrosis, ascites), malnutrition, prematurity, arrested testicular descent, connective tissue disorders, and a history of incarceration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=see_link\">",
"       \"Patient information: Inguinal and femoral (groin) hernias (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/44/42689?source=see_link\">",
"       \"Patient information: Groin (inguinal) hernias in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An inguinal hernia develops when the processus vaginalis fails to obliterate during late gestation, allowing communication between the abdominal cavity and the inguinal canal to persist. Abdominal contents can then herniate into the inguinal canal. The vast majority of hernias in children are indirect, with contents protruding through the internal inguinal ring into the inguinal canal (",
"      <a class=\"graphic graphic_figure graphicRef78798 \" href=\"UTD.htm?16/4/16453\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef60403 graphicRef57672 \" href=\"UTD.htm?9/38/9834\">",
"       figure 2A-B",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef67349 graphicRef82091 \" href=\"UTD.htm?9/9/9367\">",
"       figure 3A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Embryology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inguinal hernias in children generally present in the first year of life as an intermittent, reducible inguinal mass. The diagnosis may be made by history alone, without the presence of a mass on physical examination. Between 14 and 31 percent of cases will be incarcerated at the time of diagnosis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of an inguinal mass are described in detail above. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of inguinal hernia ultimately requires surgical repair. Incarcerated hernias must be emergently reduced:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Children with a compatible history and those with a reducible mass should be referred to a surgeon for evaluation. Because incarceration can occur in children awaiting elective repair, particularly in those less than one year of age, we suggest that repair be performed soon after diagnosis (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'No mass, reducible mass'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that manual reduction be attempted for children with an incarceration without signs of peritoneal irritation (",
"      <a class=\"graphic graphic_figure graphicRef53146 \" href=\"UTD.htm?25/45/26327\">",
"       figure 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef62707 \" href=\"UTD.htm?26/48/27398\">",
"       figure 8",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Immediate referral to a surgeon is recommended if manual reduction is not successful. Children with an incarcerated hernia should have nothing by mouth, in case emergent surgical reduction is required. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Incarcerated inguinal hernia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hernias in females are caused by the persistence of the diverticulum of Nuck and contain the suspensory ligament of the ovary. Because of the significant likelihood that reproductive organs are within the hernial sac, the clinician should attempt a gentle reduction and then obtain an ultrasound (US) if",
"      <strong>",
"       not",
"      </strong>",
"      successful. In patients in whom an incarcerated ovary is suspected, ultrasound first, if available, is an alternative approach. If the US indicates that reproductive organs are not present, then further efforts at reduction are appropriate. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Inguinal mass in a female'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following successful manual reduction of an incarcerated inguinal hernia, children should be referred to a surgeon. We suggest that definitive hernia repair be performed within five days (within two days for infants born prematurely) of the reduction (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Timing of repair'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/1\">",
"      Grosfeld JL. Current concepts in inguinal hernia in infants and children. World J Surg 1989; 13:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/2\">",
"      Kapur P, Caty MG, Glick PL. Pediatric hernias and hydroceles. Pediatr Clin North Am 1998; 45:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/3\">",
"      Rowe MI, Copelson LW, Clatworthy HW. The patent processus vaginalis and the inguinal hernia. J Pediatr Surg 1969; 4:102.",
"     </a>",
"    </li>",
"    <li>",
"     Aiken JJ. Inguinal hernias. In: Nelson Textbook of Pediatrics, 17th, Behman RE, Kliegman RM, Jenson HB.  (Eds), Saunders, Philadelphia 2004. p.1293.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/5\">",
"      Tanyel FC, M&uuml;ft&uuml;oglu S, Dagdeviren A, et al. Myofibroblasts defined by electron microscopy suggest the dedifferentiation of smooth muscle within the sac walls associated with congenital inguinal hernia. BJU Int 2001; 87:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/6\">",
"      Iason, A. Hernia in infancy and childhood. Am J Surg 1945; 68:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/7\">",
"      Misra D, Hewitt G, Potts SR, et al. Inguinal herniotomy in young infants, with emphasis on premature neonates. J Pediatr Surg 1994; 29:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/8\">",
"      George EK, Oudesluys-Murphy AM, Madern GC, et al. Inguinal hernias containing the uterus, fallopian tube, and ovary in premature female infants. J Pediatr 2000; 136:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/9\">",
"      Bijnens E, Broeckx J, Hoffbauer R, Borreman JP. Sonographic diagnosis of an incarcerated inguinal hernia containing uterus and left adnex A. J Ultrasound Med 1992; 11:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/10\">",
"      Ando H, Kaneko K, Ito F, et al. Anatomy of the round ligament in female infants and children with an inguinal hernia. Br J Surg 1997; 84:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/11\">",
"      Bronsther B, Abrams MW, Elboim C. Inguinal hernias in children--a study of 1,000 cases and a review of the literature. J Am Med Womens Assoc 1972; 27:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/12\">",
"      FOSBURG RG, MAHIN HP. FEMORAL HERNIA IN CHILDREN. Am J Surg 1965; 109:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/13\">",
"      Immordino PA. Femoral hernia in infancy and childhood. J Pediatr Surg 1972; 7:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/14\">",
"      Peevy KJ, Speed FA, Hoff CJ. Epidemiology of inguinal hernia in preterm neonates. Pediatrics 1986; 77:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/15\">",
"      Harper RG, Garcia A, Sia C. Inguinal hernia: a common problem of premature infants weighing 1,000 grams or less at birth. Pediatrics 1975; 56:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/16\">",
"      Skoog SJ, Conlin MJ. Pediatric hernias and hydroceles. The urologist's perspective. Urol Clin North Am 1995; 22:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/17\">",
"      Rescorla FJ, Grosfeld JL. Inguinal hernia repair in the perinatal period and early infancy: clinical considerations. J Pediatr Surg 1984; 19:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/18\">",
"      Rowe MI, Clatworthy HW Jr. The other side of the pediatric inguinal hernia. Surg Clin North Am 1971; 51:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/19\">",
"      Puri P, Guiney EJ, O'Donnell B. Inguinal hernia in infants: the fate of the testis following incarceration. J Pediatr Surg 1984; 19:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/20\">",
"      CLATWORTHY WH Jr, THOMPSON AG. Incarcerated and strangulated inguinal hernia in infants: a preventable risk. J Am Med Assoc 1954; 154:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/21\">",
"      Stylianos S, Jacir NN, Harris BH. Incarceration of inguinal hernia in infants prior to elective repair. J Pediatr Surg 1993; 28:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/22\">",
"      Rowe MI, Clatworthy HW. Incarcerated and strangulated hernias in children. A statistical study of high-risk factors. Arch Surg 1970; 101:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/23\">",
"      Chen YC, Wu JC, Liu L, et al. Correlation between ventriculoperitoneal shunts and inguinal hernias in children: an 8-year follow-up. Pediatrics 2011; 128:e121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/24\">",
"      German J, Simpson JL, Morillo-Cucci G, et al. Testicular feminisation and inguinal hernia. Lancet 1973; 1:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/25\">",
"      Sarpel U, Palmer SK, Dolgin SE. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J Pediatr Surg 2005; 40:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/26\">",
"      Viner RM, Teoh Y, Williams DM, et al. Androgen insensitivity syndrome: a survey of diagnostic procedures and management in the UK. Arch Dis Child 1997; 77:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/27\">",
"      Katz DA. Evaluation and management of inguinal and umbilical hernias. Pediatr Ann 2001; 30:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/28\">",
"      Erez I, Schneider N, Glaser E, Kovalivker M. Prompt diagnosis of 'acute groin' conditions in infants. Eur J Radiol 1992; 15:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/29\">",
"      Stephens BJ, Rice WT, Koucky CJ, Gruenberg JC. Optimal timing of elective indirect inguinal hernia repair in healthy children: clinical considerations for improved outcome. World J Surg 1992; 16:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/30\">",
"      Zamakhshary M, To T, Guan J, Langer JC. Risk of incarceration of inguinal hernia among infants and young children awaiting elective surgery. CMAJ 2008; 179:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/31\">",
"      Osifo OD, Ovueni ME. Inguinal hernia in Nigerian female children: beware of ovary and fallopian tube as contents. Hernia 2009; 13:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/32\">",
"      Jedrzejewski G, Stankiewicz A, Wieczorek AP. Uterus and ovary hernia of the canal of Nuck. Pediatr Radiol 2008; 38:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/33\">",
"      Merriman TE, Auldist AW. Ovarian torsion in inguinal hernias. Pediatr Surg Int 2000; 16:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/34\">",
"      Stringer MD, Higgins M, Capps SN, Holmes SJ. Irreducible inguinal hernia. Br J Surg 1991; 78:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/35\">",
"      Gahukamble DB, Khamage AS. Early versus delayed repair of reduced incarcerated inguinal hernias in the pediatric population. J Pediatr Surg 1996; 31:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/36\">",
"      Moss RL, Hatch EI Jr. Inguinal hernia repair in early infancy. Am J Surg 1991; 161:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/37\">",
"      Davies N, Najmaldin A, Burge DM. Irreducible inguinal hernia in children below two years of age. Br J Surg 1990; 77:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/38\">",
"      Rowe MI, Marchildon MB. Inguinal hernia and hydrocele in infants and children. Surg Clin North Am 1981; 61:1137.",
"     </a>",
"    </li>",
"    <li>",
"     Clark M. Hernia reduction. In: Textbook of Pediatric Emergency Procedures, 1st, Henretig FM, King C.  (Eds), Williams &amp; Wilkins, Baltimore 1997. p.927.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/40\">",
"      Kaya M, H&uuml;ckstedt T, Schier F. Laparoscopic approach to incarcerated inguinal hernia in children. J Pediatr Surg 2006; 41:567.",
"     </a>",
"    </li>",
"    <li>",
"     Paidas C, Kayton ML. Inguinal hernia. In: Oski's Pediatrics: Principles and Practice, 4th, McMillan JA, DeAngelis CD, Feigin RD, et al.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1925.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/42\">",
"      Othersen HB Jr. The pediatric inguinal hernia. Surg Clin North Am 1993; 73:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/43\">",
"      Spurbeck WW, Prasad R, Lobe TE. Two-year experience with minimally invasive herniorrhaphy in children. Surg Endosc 2005; 19:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/44\">",
"      Schier F. Laparoscopic inguinal hernia repair-a prospective personal series of 542 children. J Pediatr Surg 2006; 41:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/45\">",
"      Schier F, Montupet P, Esposito C. Laparoscopic inguinal herniorrhaphy in children: a three-center experience with 933 repairs. J Pediatr Surg 2002; 37:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/46\">",
"      Takehara H, Yakabe S, Kameoka K. Laparoscopic percutaneous extraperitoneal closure for inguinal hernia in children: clinical outcome of 972 repairs done in 3 pediatric surgical institutions. J Pediatr Surg 2006; 41:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/47\">",
"      Steinau G, Treutner KH, Feeken G, Schumpelick V. Recurrent inguinal hernias in infants and children. World J Surg 1995; 19:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/48\">",
"      Wang KS, Committee on Fetus and Newborn, American Academy of Pediatrics, Section on Surgery, American Academy of Pediatrics. Assessment and management of inguinal hernia in infants. Pediatrics 2012; 130:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/49\">",
"      Wiener ES, Touloukian RJ, Rodgers BM, et al. Hernia survey of the Section on Surgery of the American Academy of Pediatrics. J Pediatr Surg 1996; 31:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/50\">",
"      Antonoff MB, Kreykes NS, Saltzman DA, Acton RD. American Academy of Pediatrics Section on Surgery hernia survey revisited. J Pediatr Surg 2005; 40:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/51\">",
"      Tackett LD, Breuer CK, Luks FI, et al. Incidence of contralateral inguinal hernia: a prospective analysis. J Pediatr Surg 1999; 34:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/52\">",
"      Kemmotsu H, Oshima Y, Joe K, Mouri T. The features of contralateral manifestations after the repair of unilateral inguinal hernia. J Pediatr Surg 1998; 33:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/53\">",
"      Miltenburg DM, Nuchtern JG, Jaksic T, et al. Meta-analysis of the risk of metachronous hernia in infants and children. Am J Surg 1997; 174:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/54\">",
"      Manoharan S, Samarakkody U, Kulkarni M, et al. Evidence-based change of practice in the management of unilateral inguinal hernia. J Pediatr Surg 2005; 40:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/55\">",
"      Klin B, Efrati Y, Abu-Kishk I, et al. The contribution of intraoperative transinguinal laparoscopic examination of the contralateral side to the repair of inguinal hernias in children. World J Pediatr 2010; 6:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/56\">",
"      S&ouml;z&uuml;bir S, Ekingen G, Senel U, et al. A continuous debate on contralateral processus vaginalis: evaluation technique and approach to patency. Hernia 2006; 10:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/57\">",
"      Miltenburg DM, Nuchtern JG, Jaksic T, et al. Laparoscopic evaluation of the pediatric inguinal hernia--a meta-analysis. J Pediatr Surg 1998; 33:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/58\">",
"      Mollen KP, Kane TD. Inguinal hernia: what we have learned from laparoscopic evaluation of the contralateral side. Curr Opin Pediatr 2007; 19:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/59\">",
"      Walc L, Bass J, Rubin S, Walton M. Testicular fate after incarcerated hernia repair and/or orchiopexy performed in patients under 6 months of age. J Pediatr Surg 1995; 30:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/60\">",
"      Matsuda T, Muguruma K, Horii Y, et al. Serum antisperm antibodies in men with vas deferens obstruction caused by childhood inguinal herniorrhaphy. Fertil Steril 1993; 59:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/61\">",
"      Matsuda T, Muguruma K, Hiura Y, et al. Seminal tract obstruction caused by childhood inguinal herniorrhaphy: results of microsurgical reanastomosis. J Urol 1998; 159:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/62\">",
"      Boley SJ, Cahn D, Lauer T, et al. The irreducible ovary: a true emergency. J Pediatr Surg 1991; 26:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/63\">",
"      Alzahem A. Laparoscopic versus open inguinal herniotomy in infants and children: a meta-analysis. Pediatr Surg Int 2011; 27:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/3/21561/abstract/64\">",
"      Shalaby R, Ismail M, Dorgham A, et al. Laparoscopic hernia repair in infancy and childhood: evaluation of 2 different techniques. J Pediatr Surg 2010; 45:2210.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6476 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-486B9E35E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21561=[""].join("\n");
var outline_f21_3_21561=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hydrocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Incarceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Strangulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EMBRYOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Testes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ovaries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Incarceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Associated conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      No mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Reducible mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Incarcerated mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      No mass, reducible mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Inguinal mass in a female",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Incarcerated inguinal hernia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Manual reduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Surgical reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Surgical repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Timing of repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Contralateral exploration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6476\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6476|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/4/16453\" title=\"figure 1\">",
"      Testicular descent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/59/20408\" title=\"figure 2A\">",
"      Inguinal anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/35/14898\" title=\"figure 2B\">",
"      Spermatic cord course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/36/11841\" title=\"figure 3A\">",
"      Indirect inguinal hernia A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/31/25074\" title=\"figure 3B\">",
"      Indirect inguinal hernia B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/16/256\" title=\"figure 4\">",
"      Communicating hydrocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/31/24050\" title=\"figure 5\">",
"      Direct inguinal hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/13/13523\" title=\"figure 6\">",
"      Femoral hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/45/26327\" title=\"figure 7\">",
"      Inguinal hernia reduction 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/48/27398\" title=\"figure 8\">",
"      Inguinal hernia reduction 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6476|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/2/24619\" title=\"table 1\">",
"      Causes of inguinal swelling in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/47/43766?source=related_link\">",
"      Causes of painless scrotal swelling in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=related_link\">",
"      Causes of scrotal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=related_link\">",
"      Clinical manifestations and initial management of infants with bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17096?source=related_link\">",
"      Diagnosis and treatment of disorders of the androgen receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22185?source=related_link\">",
"      Evaluation of inguinal swelling in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2663?source=related_link\">",
"      Evaluation of scrotal pain or swelling in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/44/42689?source=related_link\">",
"      Patient information: Groin (inguinal) hernias in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=related_link\">",
"      Patient information: Inguinal and femoral (groin) hernias (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/23/44407?source=related_link\">",
"      Prune-belly syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17098?source=related_link\">",
"      Undescended testes (cryptorchidism) in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_3_21562="Musculoskeletal screen 1";
var content_f21_3_21562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 609px\">",
"   <div class=\"ttl\">",
"    The pGALS musculoskeletal screen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 589px; height: 770px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     pGALS: pediatric Gait Arms Legs Spine.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Foster, HE, Jandial, S. pGALS - A Screening Examination of the Musculoskeletal System in School-Aged Children. Reports on the Rheumatic Diseases (Series 5), Hands On 15. Arthritis Research Campaign; 2008 June. Copyright &copy;2008 Arthritis Research Campaign.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21562=[""].join("\n");
var outline_f21_3_21562=null;
var title_f21_3_21563="Anorec manom fecal incontinence";
var content_f21_3_21563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Influence of anorectal manometry in 56 patients with fecal incontinence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnosis confirmed",
"       </td>",
"       <td>",
"        98",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        New information",
"       </td>",
"       <td>",
"        98",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Influenced management",
"       </td>",
"       <td>",
"        84",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal study",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal study but no change in management",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Referred for",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Biofeedback",
"       </td>",
"       <td class=\"sublist_other\">",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Surgery",
"       </td>",
"       <td class=\"sublist_other\">",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Medical management",
"       </td>",
"       <td class=\"sublist_other\">",
"        4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Rao, SS, Patel, RS, Am J Gastroenterol 1997; 92:469.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21563=[""].join("\n");
var outline_f21_3_21563=null;
var title_f21_3_21564="Motor features of Parkinson disease";
var content_f21_3_21564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Motor features of Parkinson disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Cardinal manifestations",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tremor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bradykinesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rigidity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Postural instability",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Other motor features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Craniofacial",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hypomimia (masked facial expression)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Decreased eye blinking",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Speech disturbances (hypokinetic dysarthria, hypophonia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dysphagia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sialorrhea",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Visual",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Blurred vision",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Impaired contrast sensitivity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hypometric saccades",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Impaired vestibuloocular reflex",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Impaired upward gaze and convergence",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lid apraxia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Musculoskeletal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Micrographia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dystonia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Myoclonus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stooped posture",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Camptocormia (severe anterior flexion of the thoracolumbar spine)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Kyphosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Scoliosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Difficulty turning in bed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Gait",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Shuffling, short-stepped gait",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Freezing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Festination",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21564=[""].join("\n");
var outline_f21_3_21564=null;
var title_f21_3_21565="Delayed closure ant fontanelle";
var content_f21_3_21565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of delayed closure of the anterior fontanelle",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Common causes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Normal variation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Congenital hypothyroidism",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Primary megalencephaly",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Increased intracranial pressure (of any etiology)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Down syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rickets",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Skeletal disorders",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Achondroplasia*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Osteogenesis imperfecta*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cleidocranial dysostosis*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Apert syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Campomelic dysplasia",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Otopalatodigital syndrome, Type II",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Achondrogenesis-hypochondrogenesis, Type II",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Acrocallosal syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Antley-Bixler syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hypophosphatasia*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Pycnodysostosis*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Schinzel-Giedion syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Kenny syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Lenz-Majewski hyperostosis*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Stanesco dysostosis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Chromosomal abnormalities",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Down syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Trisomy 13*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Trisomy 18*",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Endocrine disorders",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hypothyroidism*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rickets*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Drugs/toxins",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fetal hydantoin syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aminopterin-induced malformation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aluminum toxicity",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Dysmorphogenetic syndromes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Russell-Silver syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rubinstein-Taybi syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hallermann-Streiff syndrome* (Oculomandibulofacial syndrome)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Zellweger syndrome* (cerebrohepatorenal syndrome)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Robinow syndrome*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cutis laxa*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Progeria",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          VATER association*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aase syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Melnick-Needles syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Conradi-Hunermann syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Otopalatodigital syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Saethre-Chotzen syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Miscellaneous",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Primary megalencephaly",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Malnutrition*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Congenital syphilis*",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Also associated with an enlarged fontanelle.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      Tunnessen, WW. Delayed closure of the anterior fontanelle. In: Signs and Symptoms in Pediatrics, 3rd ed, Lippincott, Williams &amp; Wilkins, Philadelphia 1999. p.192.",
"      <br>",
"       Tunnessen, WW. Enlarged anterior fontanelle. In: Signs and Symptoms in Pediatrics, 3rd ed, Lippincott, Williams &amp; Wilkins, Philadelphia 1999. p.187.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21565=[""].join("\n");
var outline_f21_3_21565=null;
var title_f21_3_21566="Monoclonal pattern on SPEP";
var content_f21_3_21566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Monoclonal pattern on serum protein electrophoresis (SPEP)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 278px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Densitometer tracing of these findings reveals a tall, narrow-based peak (red asterisk) of gamma mobility and has been likened to a church spire. The monoclonal band has a densitometric appearance similar to that of albumin (alb) and a reduction in the normal polyclonal gamma band.",
"    <br>",
"     (B) A dense, localized band (red asterisk) representing a monoclonal protein of gamma mobility is seen on serum protein electrophoresis on agarose gel (anode on left).",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Kyle, RA, Rajkumar, SV. Plasma cell disorders. In: Cecil textbook of medicine, 22nd ed, Goldman, L, Ausiello, DA (Eds), WB Saunders, Philadelphia 2004. p.1184. Copyright &copy; 2004 Elsevier.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21566=[""].join("\n");
var outline_f21_3_21566=null;
var title_f21_3_21567="PCP of liver after OLT";
var content_f21_3_21567=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F62475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F62475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumocystis carinii in transplanted liver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound image of the liver in a transplant recipient with fever, cough and elevated liver enzymes demonstrates multiple bright foci scattered throughout the liver due to Pneumocytis carinii microabscesses. This is the so-called starry-sky appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_3_21567=[""].join("\n");
var outline_f21_3_21567=null;
